DESIGN AND CONSTRUCTION OF BIOSENSING PLATFORMS FOR THE DETECTION OF BIOMARKERS by DENG HUIMIN
DESIGN AND CONSTRUCTION OF BIOSENSING 






(B. Sc., SICHUAN UNIVERSITY) 
 
 
A THESIS SUBMITTED 
FOR THE DEGREE OF DOCTOR OF 
PHILOSOPHY 
DEPARTMENT OF CHEMISTRY 






I hereby declare that this thesis is my original work and it has been written 
by me in its entirety, under the supervision of Assoc. Prof. Gao Zhiqiang, (in 
the Biosensors and Electroanalytical Laboratory located at S5-02-03), 
Chemistry Department, National University of Singapore, between August 
2011 and April 2015. I have duly acknowledged all the sources of information 
which have been used in the thesis. This thesis has also not been submitted for 
any degree in any university previously. 
The content of the thesis has been partially published in: 
1. H. M. Deng, W. Shen, Z. Q. Gao, Chemphyschem. 2013, 14, 2343-
2347. 
2. H. M. Deng, A. K. L. Teo, Z. Q. Gao, Sensor. Actuat. B-Chem. 2014, 
191, 522-528. 
3. H. M. Deng, X. J. Yang, S. P. X. Yeo, Z. Q. Gao, Anal. Chem. 2014, 
86, 2117-2123. 
4. H. M. Deng, X. J. Yang, Z. Q. Gao, Analyst 2015, 140, 3210-3215. 
5. X. M. Guo, H. M. Deng, H. Zhou, T. X. Fan, Z. Q. Gao, Sensor. 
Actuat. B-Chem. 2015, 206, 721-727. 
 
 Deng Huimin                                                                             April, 2015 







First and foremost, I would like to thank my supervisor, Assoc. Prof. Gao 
Zhiqiang, for his guidance, help, and timely advice during my PhD study. His 
efficiency, immense knowledge, and critical thinking in scientific research 
have inspired me a lot. I really appreciate his patience in guiding me on the 
academic writing and revising my manuscripts. 
I would also like to thank the research fellow in our laboratory, Dr. Yang 
Xinjian, for his useful suggestions on the design of my experiments and the 
discussion on the experimental results. 
I would like to express my gratitude to the honors students Mr. Teo Kay 
Liang Alan, Ms. Yeo Pei Xing Stephanie, and Ms. Png Si Ying for their 
cooperation in the final year projects which have been included partially in my 
thesis. I am also grateful to my other lab mates Ms. Shen Wei, Dr. Li Ying, Dr. 
Shnamuga Sundaram Komathi, Ms. Ren Yuqian, Ms. Zhang Yanmei, Ms. Guo 
Xingmei, Mr. Chen Chengbo, and Ms. Guo Yuwenxi for their help. 
I really appreciate my family and friends for their support and 
encouragements. I especially thank my parents, Mr. Deng Xianshun and Mdm. 
Tan Meirong, for their endless love and being a pillar of strength during my 
frustration period during my PhD study. 
Financial support from National University of Singapore is gratefully 
acknowledged.        
 iii 
 
Table of Contents 
 
Declaration ..................................................................................................................... i 
Acknowledgements ....................................................................................................... ii 
Table of Contents ......................................................................................................... iii 
Summary ..................................................................................................................... vii 
List of Tables ................................................................................................................ x 
List of Figures .............................................................................................................. xi 
List of Schemes ........................................................................................................... xv 
List of Abbreviations ................................................................................................. xvi 
Chapter 1. Introduction ................................................................................................. 1 
1.1 Biosensors ........................................................................................................... 2 
1.1.1 Definition of a biosensor .............................................................................. 2 
1.1.2 Applications of biosensors ........................................................................... 3 
1.1.3 Classification of biosensors ......................................................................... 4 
1.2 Glucose biosensors.............................................................................................. 7 
1.2.1 Diabetes mellitus and glucose sensing ......................................................... 7 
1.2.2 History of electrochemical glucose biosensors ............................................ 9 
1.2.2.1 First generation of glucose biosensors ................................................ 10 
1.2.2.2 Second generation of glucose biosensors ............................................ 11 
1.2.2.3 Third generation of glucose biosensors .............................................. 12 
1.2.3 Interference issue in electrochemical glucose biosensors .......................... 13 
1.2.3.1 Permselective membrane covering ..................................................... 13 
1.2.3.2 Operation potential lowering .............................................................. 14 
1.3 DNA MTase activity biosensors ....................................................................... 15 
1.3.1 DNA methylation ....................................................................................... 15 
1.3.2 DNA MTase biomarker in cancer .............................................................. 17 
1.3.3 Methods for the detection of DNA MTase activity ................................... 19 
1.3.3.1 Electrochemical DNA MTase biosensors ........................................... 20 
1.3.3.2 Optical DNA MTase activity biosensors ............................................ 22 
1.4 Objectives and significance of the studies ........................................................ 24 
1.5 Scope and overview of the thesis ...................................................................... 25 
 iv 
 
Chapter 2. An interference-free glucose biosensor based on an anionic redox 
polymer-mediated enzymatic oxidation of glucose .................................................... 29 
2.1 Introduction ....................................................................................................... 29 
2.2 Experimental ..................................................................................................... 29 
2.2.1 Materials and apparatus ............................................................................. 29 
2.2.2 Glucose Biosensor Fabrication .................................................................. 31 
2.3. Results and discussion ..................................................................................... 31 
2.3.1 Electrochemical Characteristics of the Biosensor ...................................... 31 
2.3.2 Optimization .............................................................................................. 34 
2.3.3 Analytical Performance of the Biosensor .................................................. 37 
2.4. Conclusion ....................................................................................................... 40 
Chapter 3. An interference-free glucose biosensor based on a novel low potential 
redox polymer mediator .............................................................................................. 41 
3.1 Introduction ....................................................................................................... 41 
3.2 Experimental ..................................................................................................... 42 
3.2.1 Reagents and appratus ................................................................................ 42 
3.2.2. Preparation of the redox polymer .............................................................. 43 
3.2.3. Preparation of the biosensor ...................................................................... 43 
3.3 Results and discussion ...................................................................................... 44 
3.3.1. Synthesis and characterization of the Ru-RP ............................................ 44 
3.3.2. Electrochemical characteristics of the biosensor ...................................... 46 
3.3.3. Optimization of the biosensor ................................................................... 50 
3.3.4. Analytical performance of the biosensor ...................................................... 52 
3.4 Conclusion ........................................................................................................ 58 
Chapter 4. Detection of glucose with a lamellar-ridge architecture gold modified 
electrode ...................................................................................................................... 60 
4.1 Introduction ....................................................................................................... 60 
4.2 Experimental ..................................................................................................... 62 
4.2.1 Reagents and apparatus .............................................................................. 62 
4.2.2 Preparation of gold samples ....................................................................... 63 
4.2.3 Glucose sensor fabrication ......................................................................... 64 
4.2.4 Cyclic voltammetric and amperometric experiment .................................. 65 
4.2.5 Finite element simulation ........................................................................... 65 
4.3 Results and discussion ...................................................................................... 65 
4.3.1 Architecture and composition characterization .......................................... 65 
 v 
 
4.3.2 Electrochemical examination ..................................................................... 67 
4.3.3 Amperometric detection of glucose ........................................................... 69 
4.3.4 Mass transport analysis .............................................................................. 73 
4.4 Conclusion ........................................................................................................ 74 
Chapter 5. A highly sensitive electrochemical methyltransferase activity biosensor . 76 
5.1 Introduction ....................................................................................................... 76 
5.2 Experimental ..................................................................................................... 76 
5.2.1 Reagents and apparatus .............................................................................. 76 
5.2.2 M.SssI MTase catalyzed DNA methylation event confirmation by gel 
electrophoresis .................................................................................................... 78 
5.2.3 Double-stranded DNA and electrode preparation ...................................... 79 
5.2.4 MTase activity detection ............................................................................ 80 
5.2.5 Selectivity and inhibition investigation of the M.SssI MTase biosensor ... 80 
5.3 Results and discussion ...................................................................................... 81 
5.3.1 MTase activity biosensor principle ............................................................ 81 
5.3.2 Electrochemical characterization of modified electrode and feasibility 
study .................................................................................................................... 84 
5.3.3 M.SssI MTase activity determination ........................................................ 89 
5.3.4 Selectivity of the M.SssI MTase activity biosensor ................................... 90 
5.3.5 Influence of inhibitors on M.SssI MTase activity ...................................... 91 
5.4 Conclusion ........................................................................................................ 93 
Chapter 6. MoS2 nanosheets as an effective fluorescence quencher for DNA 
methyltransferase activity detection............................................................................ 94 
6.1 Introduction ....................................................................................................... 94 
6.2 Experimental ..................................................................................................... 95 
6.2.1 Materials and apparatus ............................................................................. 95 
6.2.2 Preparation of MoS2 nanosheets ................................................................ 96 
6.2.3 Feasibility study ......................................................................................... 97 
6.2.4 Dam methyltransferase activity detection .................................................. 98 
6.2.5 Selectivity and inhibition study.................................................................. 98 
6.3 Results and discussion ...................................................................................... 99 
6.3.1 Characterization of MoS2 nanosheets ........................................................ 99 
6.3.2 Principle and feasibility of the Dam MTase activity biosensor ............... 101 
6.3.3 Dam methyltransferase activity detection ................................................ 104 
6.3.4 Selectivity and inhibition study................................................................ 109 
 vi 
 
6.4 Conclusion ...................................................................................................... 111 
Chapter 7. DAN methyltransferase activity detection using a personal glucose meter
 .................................................................................................................................. 112 
7.1 Introduction ..................................................................................................... 112 
7.2 Experimental ................................................................................................... 114 
7.2.1 Reagents and apparatus ............................................................................ 114 
7.2.2 Preparation and characterization of DNA-invertase conjugates .............. 115 
7.2.3 Hybridization of oligo 2 and oligo 1-invertase conjugates ...................... 116 
7.2.4 Immobilization of ds-DNA-invertase onto magnetic beads ..................... 116 
7.2.5 Optimization ............................................................................................ 117 
7.2.6 Detection of M.SssI MTase activity using the PGM ............................... 117 
7.2.7 Selectivity study ....................................................................................... 118 
7.3 Results and discussion .................................................................................... 118 
7.3.1 Principle and feasibility of the portable M.SssI MTase activity biosensor
 .......................................................................................................................... 118 
7.3.2 Optimization ............................................................................................ 121 
7.3.3 Calibration study ...................................................................................... 123 
7.3.4 Selectivity study of the proposed M.SssI MTase activity biosensor........ 124 
7.4 Conclusion ...................................................................................................... 125 
Chapter 8. Conclusion and future outlook ................................................................ 126 
8.1 Conclusion ...................................................................................................... 126 
8.1.1 Glucose biosensors ................................................................................... 126 
8.1.2 DNA MTase activity biosensors .............................................................. 128 
8.2 Future outlook ................................................................................................. 130 







Biosensors can provide cost-effective, easy-to-use, sensitive and highly 
accurate detection devices in a variety of research and commercial 
applications. This thesis focuses on the development of novel biosensing 
platforms for glucose and deoxyribonucleic acid (DNA) methyltransferase 
(MTase) activity detection. 
Firstly, two different types of mediators are employed to construct highly 
sensitive and selective electrochemical glucose biosensors with excellent anti-
interference characteristics. One is an osmium-bipyridine complex (Os(bpy)2) 
-based anionic redox polymer (Os-RP), and the other is a novel ruthenium 
complex-tethered redox polymer (Ru-RP). The biosensing membranes are 
formed through the co-immobilization of glucose oxidase (GOx) and the 
mediators on the surfaces of glassy carbon electrodes (GCE) in a simple one-
step chemical crosslinking process. Both the fabricated Os-RP/GOx and the 
Ru-RP/GOx biosensors show excellent electrocatalytic activity toward the 
oxidation of glucose and exhibit good linear correlations between the 
oxidation current and the glucose concentration up to 10 mM with a sensitivity 
of 16.5 and 24.3 A mM-1 cm-2, respectively. Moreover, both glucose 
biosensors display outstanding anti-interference capabilities resulting from the 
presence of anionic sulfonic acid groups in the backbones of the Os-RP and 
the ultralow working potential (-0.15 V) of the Ru-RP, respectively. In 
addition, a novel lamellar-ridge architectured gold (lamellar ridge-Au) 
material is prepared using blue scales of Morph butterfly as templates. 
 viii 
 
Prominent performance in the nonenzymatic detection of glucose using a 
lamellar ridge-Au modified electrode is achieved with a wide linear range 
from 2 μM to 23 mM with a sensitivity of 29.0 A mM-1 cm-2. This is 
attributed to the synergistic effect of increased surface area and efficient mass 
transport of the architectured lamellar ridge-Au. 
Secondly, three types of DNA MTase activity biosensors are established 
coupling with the methylation sensitive restriction endonuclease. In general, 
the principle of these biosensors depends on the changes in signal producers 
bound or labeled to the substrate DNA of MTase, which result from the 
methylation-cleavage events catalyzed by the MTase and endonuclease. In the 
first MTase biosensor, a synthetic threading intercalator, N,N’-bis(3-
propylimidazole)-1,4,5,8-naphthalene diimide (PIND) functionalized with 
electrocatalytic redox Os(bpy)2Cl
+
 moieties (PIND-Os), which strongly and 
selectively binds to double-stranded DNA (ds-DNA) and catalyzes the 
oxidation of ascorbic acid (AA), is employed to reflect the DNA methylation 
level and to provide a highly sensitive electrochemical signal. A linear 
correlation between the catalytic oxidation current of AA and the activity of 
M.SssI MTase ranged from 0 to 120 U/mL with a current sensitivity of 0.046 
μA mL U−1 is obtained. In the second MTase biosensor, layered transition 
metal dichalcogenides – MoS2 nanosheets are used as a fluorescence quencher 
for the construction of a simple signal-on fluorescent MTase sensor. The 
fluorescence signal mainly relies on the restored fluorescence which results 
from the affinity difference of fluorophore labeled long (>10 bases) and short 
(5 bases) DNA strands produced before and after the methylation process. 
Based on this principle, a linear correlation between the restored fluorescence 
 ix 
 
intensity and the Dam MTase activity ranged from 0.2 to 20 U/mL is achieved. 
In the third MTase biosensor, invertase which catalyzes the hydrolysis of 
sucrose into glucose and fructose is conjugated with the substrate DNA to act 
as the signal producer. The resulting glucose is then monitored by a personal 
glucose meter (PGM). Taking advantage of the ease of operation, low cost, 
and readily accessibility characteristics of the PGM, a linear relationship 
between the glucose reading and the Dam MTase activity from 0.5 to 80 U/mL 
is achieved, offering a good opportunity for the development of simple and 
robust MTase activity detection tool for uses at point-of-care. Excellent 
sensitivity and selectivity for MTase activity measurements are attained in 
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Chapter 1. Introduction 
 
Diabetes mellitus, a kind of metabolic disease characterized by high blood 
sugar (glucose) levels, has long been a worldwide public health problem. In 
2013, 382 million people had diabetes; this number is expected to rise to 592 
million by 2035.
1
 Patients with diabetes risk serious complications from heart 
disease, kidney failure, nerve degradation, blindness, and amputations.
2
 
Highly sensitive, selective, and reliable detection of glucose is of great 
importance for diabetes mellitus diagnosis and management. 
DNA methyltransferases (MTases) are a family of enzymes that catalyze the 
transfer of a methyl group from S-adenosyl-L-methionine (SAM) to adenine 
or cytosine residues in the specific sites of DNA during the biological DNA 
methylation process.
3
 In mammals, abnormal DNA methylation patterns 
caused by altered DNA MTase activity have been demonstrated to be closely 
associated with human diseases including cancer.
4, 5
 Consequently, DNA 
MTases have been recognized as potential targets for early disease diagnosis. 
Therefore, the development of DNA MTase activity biosensors is critical for 
both scientific research and clinical applications. 
My research is mainly focused on the development of novel glucose and 
DNA MTase activity biosensors. In this chapter, a brief introduction on 
biosensors will be presented followed by two parallel reviews on glucose 





1.1.1 Definition of a biosensor 
According to the International Union of Pure and Applied Chemistry 
(IUPAC) nomenclature, a biosensor is defined as an analytical device that is 
capable of providing quantitative or semi-quantitative information using 
specific biochemical reactions with a physicochemical detector.
6
 As illustrated 
in Figure 1.1, it typically consists of two components, a biological recognition 
element (bioreceptor) and a transduction element (transducer). The role of the 
bioreceptor is to interact specifically with the target analyte, and the 
bioreceptor element can be an enzyme, antibody, nucleic acid, cell structure, 
organelles, microorganisms, or tissue. A comprehensive overview of various 
kinds of recognition receptors used in biosensors is available.
7
 On the other 
hand, the role of the transducer is to transform the biorecognition event 
resulting from the interaction of the analyte with the biological element into a 
detectable signal that can be more easily measured and quantified. The 
transducer usually works in a physicochemical way, for example, the 
electrochemical technique, the optical technique, the piezoelectric technique, 




Figure 1.1. Schematic illustration of a biosensor. 
 
1.1.2 Applications of biosensors 
Comparing with conventional analytical methods based on techniques such 
as spectrometry, chromatography, biochemical or microbiological techniques, 
biosensors are cost-effective, time-saving, easy-to-use, sensitive and highly 
accurate detection devices in a variety of research and commercial 
applications. To date, biosensors have found a broad range of applications in 
environmental pollution control, industrial processing and monitoring, defense, 
healthcare, and so forth.  
Environmental applications of biosensors mainly focus on the detection and 
monitoring of pollutants in soil, water, and air.
8, 9
 The most intensively 
investigated environmental biosensors are based on the detection of 
pesticides,
10





 and toxic gases (sulfur, nitrogen, and carbon oxides, 
hydrogen cyanide, etc.).
13
 In addition, various biosensors have been developed 
in order to assess the quality of foodstuff and beverage and to monitor 
industrial processes in the food and beverage industries.
14
 The majority of 
biosensor research for food industry is focused on the verification of 
maximum pesticide residues and monitoring of analyte concentrations, such as 
carbohydrates, alcohols, and acids, which may be indicators of food 
acceptability and quality. Defense in general, and defense against terror 
attacks in particular, is currently a matter of great concern that has prompted 
the development of biosensors for explosives and warfare agents.
15, 16
 Various 
types of biosensors for the detection of biological warfare agents have been 
 4 
 
developed using various recognition components, such as antibodies, enzymes, 
biologically-inspired synthetic ligands, whole-cell, etc. Moreover, one of the 
main fields of biosensor applications is healthcare in which biosensors are 
utilized for in vitro or in vivo determination of chemical species of 
physiological relevance.
17
 It is noteworthy that glucose meters for self-
monitoring of blood glucose levels for people with diabetes are commercially 
available, and accounts for about 85% of the total biosensor market.
18
 Besides, 
biosensors for different biomarkers have been developed for the clinical 





1.1.3 Classification of biosensors 
Biosensors may be classified according to the biological specificity-
conferring mechanism or, alternatively, to the mode of physicochemical signal 
transduction.
8
 The bioreceptor may be based on a chemical reaction catalyzed 
by, or on an equilibrium reaction with macromolecules that have been isolated, 
engineered or present in their original biological environment. In the latter 
case, equilibrium is generally reached and there is no further, if any, net 
consumption of analyte by the immobilized biorecognition agent incorporated 
into the biosensors. Most commonly, according to the transducing mechanism, 
biosensors are categorized as electrochemical, optical, thermometric, and 




Figure 1.2. Classification of biosensors based on transducers. 
 
The basic principle of electrochemical biosensors is that the chemical 
reactions between the bioreceptor and target analyte produce or consume ions 
or electrons, which affects measurable electrical properties of the solution.
20
 
Electrochemical biosensors can be further classified as potentiometric, 
amperometric, and impedimetric biosensors. Potentiometric biosensors deal 
with the potential difference either between an indicator and a reference 
electrode, or two reference electrodes separated by a permselective membrane. 
Amperometric biosensors are based on the measurement of the current 
resulting from the electrochemical oxidation or reduction of an electroactive 
species. Additionally, a series of electrochemical transduction methods are 
based on the concept of electrochemical impedance. The electrochemical 
impedance indicates the opposition to the flow of an alternating current 
through an electrochemical cell. Optical biosensors can be based on light 
emission or light absorption by the sensing element. Such processes are 
associated with transitions between energy levels of certain species (molecules 
or nanoparticles) included in the sensing element. Biosensors depending on 
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optical transducers may detect changes in the absorbance, 
fluorescence/phosphorescence, chemiluminescence, reflectance, light 
scattering, or refractive index.
21
 Thermometric biosensors exploit the 
fundamental property of biological reactions, i.e. absorption or evolution of 
heat, which is reflected as a change in the temperature within the reaction 
medium.
22
 The total heat evolution or absorption is proportional to the molar 
enthalpy and to the total number of product molecules created in the 
biochemical reaction. Piezoelectric biosensors rely on the mass-sensitive 
sensing technique. The mass change resulting from the recognition between 
the analyte and the sensing element is measured. They usually involve the 




In addition to the transducer-based categories described above, biosensors 
may be further classified according to the analytes or reactions that they 
monitor: direct monitoring of analyte concentration or of reactions producing 
or consuming such analytes; alternatively, an indirect monitoring of inhibitor 
or activator of the biological recognition element (biochemical receptor) may 
be achieved. My research interest is focused on two aspects, one is the 
monitoring of glucose which is of great importance for diabetes mellitus 
diagnosis and control; the other is the monitoring of DNA MTase activity 
which plays an essential role in DNA methylation related biological processes 
like gene expression, genomic imprinting, etc. In terms of these two types of 
analytes of interest, two parallel reviews on glucose biosensors and DNA 




1.2 Glucose biosensors 
1.2.1 Diabetes mellitus and glucose sensing 
Glucose is the primary source of energy for most cells of the body. In 
medicine and animal physiology, “blood sugar” refers to glucose in the blood. 
Glucose in bloodstream is regulated by hormones produced by the body. The 
human body regulates blood glucose levels at a concentration of 4-8 mM (70-
120 mg dL
−1
). In the presence of physiopathological conditions, blood glucose 




 A persistent 
high glucose level is present in patients with diabetes mellitus, since they are 
unable to effectively regulate blood glucose levels. 
Diabetes mellitus is a group of metabolic diseases characterized by 
hyperglycemia resulting from defects in insulin secretion, insulin action, or 
both.
26
 It is a leading cause of morbidity and mortality, and a major health 
problem in most developed societies. The International Diabetes Federation 
has produced estimates of diabetes prevalence since the year 2000. As of 2013, 
the latest study estimated that 382 million people had diabetes worldwide and 
this number is expected to rise to 592 million by 2035.
1
 Diabetes mellitus can 
be classified into two broad etiopathogenetic categories: type 1 and type 2 
diabetes. The former type of diabetes, which accounts for only 5-10% of the 
diabetic population, is caused by an absolute deficiency of insulin secretion, 
which resulting from a cellular-mediated autoimmune destruction of the β-
cells of the pancreas. The later type of diabetes, type 2 diabetes, is much more 
prevalent, and accounts for ~90-95% of the diabetic population. It is caused by 
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a combination of resistance to insulin action and an inadequate compensatory 
insulin secretory response. 
The chronic hyperglycemia of diabetes is associated with long-term damage, 
dysfunction, and failure of different organs. Long-term complications of 
diabetes mellitus include retinopathy with potential loss of vision; 
nephropathy leading to renal failure; peripheral neuropathy with risk of foot 
ulcers, amputations, and Charcot joints; and autonomic neuropathy causing 
gastrointestinal, genitourinary, and cardiovascular symptoms, and sexual 
dysfunction.
27
 The monitoring of blood glucose concentration is of great 
importance for the diagnosis and management of patients with diabetes. Self-
monitoring of blood glucose
 
helps the patient achieve and maintain normal 
blood glucose concentrations in order to delay or even prevent the progression 
of microvascular (retinopathy, nephropathy, and neuropathy) and 
macrovascular complications.
28
 Thus, this demand greatly promoted the 
intensive research on the development of glucose biosensors.  





 have been reported and reviewed 
by several experts. More recently, due to the rapid development of 
nanotechnology, many glucose biosensors that utilize a number of 
nanomaterials (nanoparticles, nanofilms, nanotubes, and nanocomposites) 
have been surveyed.
25, 34, 35
 Electrochemical biosensors can provide the 
advantages of cost-effective, ease of operation, fast response, and ease of 
miniaturization, glucose biosensors based on this type of transduction  
dominate the biosensor market. The following section will review the brief 
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history of electrochemical glucose biosensors and their basic operation 
principle. 
 
1.2.2 History of electrochemical glucose biosensors 
Since the conception of glucose enzyme electrode proposed by Clark and 
Lyons in 1962,
36
 numerous efforts have been made toward the development of 
electrochemical glucose biosensors for reliable determination of glucose in the 







 transductions have been established 
for electrochemical glucose detection. Among them, enzymatic amperometric 
glucose biosensors are the most common devices commercially available, and 
have been widely studied over the last few decades. Generally, glucose 
measurements are based on the catalytic oxidation by the immobilized glucose 
dehydrogenase (GDH) or glucose oxidase (GOx).
44, 45
 Although  glucose 
biosensors based on GDH have been constructed, the lack of specificity and 
stability rule out the widespread  use of this enzyme in glucose biosensors.
45
 In 
comparison, GOx is easy to obtain, cheap, and can withstand greater extremes 
of pH, ionic strength, and temperature, thus allowing less stringent conditions 
during the manufacturing process.
46
 General milestones and achievements 
relevant to electrochemical glucose biosensors are summarized in Table 1.1. 
More specifically, there are three generations of glucose biosensors, detailed 






Table 1.1. Historical landmarks of electrochemical glucose biosensors. 
Year Event References 
1962 First glucose enzyme electrode 
36
 
1967 First practical enzyme electrode 
47
 




1975 Relaunch of first commercial glucose sensor system, 
YSI analyzer 
YSI Inc. 








1987 Launch of the MediSense ExacTech blood glucose 
biosensor 
Medisense Inc. 




1999 Launch of a commercial in vivo glucose sensor MiniMed Inc. 
2000 Introduction of a wearable noninvasive glucose 
monitor 
Cygnus Inc. 









1.2.2.1 First generation of glucose biosensors 
The first generation of glucose biosensors mainly rely on the biocatalytic 
reaction involving the reduction of flavin adenine dinucleotide (FAD) in the 
glucose oxidase (GOx) by glucose, followed by the reoxidation of the reduced 
form of FAD (FADH2) by molecular oxygen (equation 1 and 2).  
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GOx (FAD) + glucose → GOx (FADH2) + gluconolactone   (1) 
GOx (FADH2) + O2 → GOx (FAD) + H2O2   (2) 
In this case, glucose concentration is indirectly monitored by either the 
consumption of molecular oxygen using an oxygen electrode
36
 or the 
production of H2O2 through amperometric measurement.
48
 However, this 
indirect glucose detection strategy is limited by two major drawbacks. The 
first limitation factor, known as the “oxygen deficit”, is the co-substrate 
molecular oxygen, due to its much lower level than glucose in blood, the 
development of highly sensitive glucose biosensors is severely affected. The 
other limitation is caused by the amperometric measurement of the produced 
H2O2, the requirement of a relatively high working potential (+ 0.6 V, vs. 
Ag/AgCl) results in the interference caused by readily oxidizable species that 
coexist in blood. 
 
1.2.2.2 Second generation of glucose biosensors 
In order to overcome the drawbacks of the first generation of glucose 
biosensors, further improvements have been obtained by replacing the natural 
molecular oxygen with mediators. Mediators are artificial electron transferring 
agents that can readily participate in the redox reaction with the biological 
component and thus help in the rapid electron transfer.
55
 The direct electron 
transfer between the FAD redox center of GOx and the electrode surface is 
impeded by the intrinsic barrier of the thick glycoprotein shell surrounding the 
active sites. The electron mediators, such as ferrocene and its derivatives, 
ferricyanide, quinine compounds, methylene blue, etc. have been widely used 
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to construct mediated glucose biosensors to help shuttling electrons between 
the redox centers of GOx and the substrate electrode.
50, 56-59
  
The operating principle of the mediated glucose biosensors is illustrated in 
Figure 1.3. Electrons are rapidly shuttled through a nondiffusional routine and 
the subsequent reoxidation of the mediator at the electrode surface produce the 
current signal which is proportional to the concentration of glucose.  
 
Figure 1.3. Working principle of mediated glucose biosensors. 
 
In addition, various strategies to facilitate electron transfer between the 
redox centers of GOx and the electrode surface have been employed, such as 
enzyme wiring of GOx by electron-conducting redox hydrogels, the chemical 
modification of GOx with electron-relay groups, and the application of 




1.2.2.3 Third generation of glucose biosensors 
Some electrodes which are prepared by the coating of the electronic 
conductors (conducting salts) have been developed. The reduced enzyme can 
be directly oxidized on these electrodes (equation 3 and 4). Glucose biosensors 
using these electrodes have been classified as the third generation of glucose 
biosensors. Several studies for other direct electron transfer approaches on the 
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third-generation glucose biosensors have been reported, including TTF-TCNQ 




GOx (FAD) + glucose → GOx (FADH2) + gluconolactone   (3) 




   (4) 
 
1.2.3 Interference issue in electrochemical glucose biosensors 
The analytical performance of glucose biosensors is usually evaluated in 
terms of precision, accuracy, linearity, and anti-interference capability. In this 
section, interference which is still a big issue in electrochemical glucose 
biosensors will be addressed. 
Although enzymes are generally very efficient and very selective, the 
amperometric glucose biosensors which operate at relatively high potentials 
often lose their selectivity due to the contribution of the electrochemical 
responses from biologically electroactive interferences. The commonly 
encountered interferences in blood fluids are ascorbic acid (AA), dopamine 





1.2.3.1 Permselective membrane covering   
To alleviate the interference problem and improve the anti-interference 
ability of the electrochemical glucose biosensors, permselective coatings with 
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transport properties based on charge or size exclusion principle have been 
utilized in the construction of glucose biosensors toward the regulation of the 
coexisting substances. For example, Nafion, which is a negatively-charged 
perfluorinated ionomer can prevent the diffusion of anionic species, such as 
AA and UA, toward the electrode, is frequently employed in the construction 
of glucose biosensors.
68-70
 Besides, polymer films (i.e. polyphenylenediamine, 
polypyrrole, polymeric mercaptosilane, etc.) and cellulose acetate membranes 




The approach of coating a permselective membrane on a biosensing layer 
provides a simple, fast way to block interferants from accessing the electrode. 
However, Nafion or other polymeric films in these methods were dispersed 
over the electrode surface by dipping or spin coating. As a result, the 
membrane thickness was hard to control. More importantly, these methods 
face the limitations of poor repeatability, non-uniformity of coating and poor 
adhesion. 
  
1.2.3.2 Operation potential lowering 
Mediated amperometric glucose biosensors are known to be less susceptible 
to interferences when they are operated at very low applied potentials. 
Therefore, paramount works have been done on the exploring of various 
mediators that pose low redox potentials. Jiang and co-workers proposed an 
osmium complex-based glucose biosensor which has a working potential of 0 
mV (vs. Ag/AgCl).
75





 was used as the mediator, it allowed the use of a relatively low 
applied potential of 0 mV (vs. Ag/AgCl).
76
 The adoption of these low working 
potential mediators could effectively eliminate interference from AA, DA, and 
UA. 
Although a number of mediators which operate at relatively low working 
potentials have been developed, it is still of great significance to explore novel 
structured mediators with even lower working potentials for practically 
completely eliminating interference. 
  
1.3 DNA MTase activity biosensors 
1.3.1 DNA methylation 
Epigenetics is defined as heritable changes in gene expression that are not 
due to any alteration in the DNA sequence.
77
 There are three main, inter-
related types of epigenetics: DNA methylation, genomic imprinting, and 
histone modification.
78
  Among them, DNA methylation is the best known 
epigenetic marker, and it is the first epigenetic modification to be 
characterized at the molecular level.
79, 80
 DNA methylation is a biochemical 
process which refers to a covalent chemical modification resulting in the 





 position) or adenine (N
6
 position) nucleotide (Figure 1.4). 
This process is brought out enzymatically by DNA MTases after DNA 
replication in a sequence-specific manner, usually at palindromic sites.
81
 
Examples of typical DNA MTases (from both prokaryotes and eukaryotes) 
involved in DNA methylation machinery are summarized in Table 1.2. DNA 
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methylation does not affect the Watson/Crick pairing properties of cytosine 
and adenine, the methyl group is positioned in the major groove of the DNA, 
where it can easily be detected by proteins interacting with the DNA. 
Table 1.2. Examples of DNA MTase. 
MTase Recognition site (5’-3’) Classification Source 
AluI AGCT C
5
-cytosine Arthrobacter luteus 
Dam GATC N
6
-adenine E. coli 
Dnmt1 Hemimethylated CG C
5
-cytosine human Dnmt1 cDNA 
HaeIII GGCC  C
5
-cytosine Haemophilus aegyptius 
Met1 CG  C
5
-cytosine A. thaliana 
M.SssI CG  C
5
-cytosine Spiroplasma sp. 
M.PvuII CAGCTG  N
4
-cytosine Proteus vulgaris 
 
DNA methylation in prokaryotes includes all three types of methylation 
illustrated in Figure 1.4. The major role of DNA methylation in prokaryotes is 
a host mechanism against foreign DNA as part of restriction modification 
systems.
82
 In higher eukaryotes, only C
5
-cytosine methylation has been found 
at the CpG dinucleotide sequence, and about 60%-90% CpG sites are 
methylated in mammals.
83
 In mammals, studies have revealed that DNA 
methylation plays an essential role in many biological processes, such as 







Figure 1.4. DNA MTase catalyzed adenine and cytosine methylation. 
 
1.3.2 DNA MTase biomarker in cancer 
Aberrant DNA methylation resulting in transcriptional repression has been 
documented in several types of human cancer,
87-90
 such as colon cancer, breast 
cancer, lung cancer, kidney cancer, prostate cancer, liver cancer, ovarian 
cancer, etc. As the catalytic enzymes in the DNA methylation process, 
alterations of DNA MTases activity have been confirmed to be closely related 
to the aberrant DNA methylation level in several diseases. Issa and co-workers 
have demonstrated that an increased DNA methylation capacity accompanies 
the increase in DNA MTase transcripts were observed during progressive 
stages of colon cancer, the cytosine DNA MTase activity was 5.4-fold in the 
cancer specimens compared with normal control subjects.
91
  Belinsky et al. 
has revealed that DNA MTase activity increased incrementally during lung 
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cancer progression and coincided with increased expression of the DNA 
MTase gene in hyperplasias, adenomas, and carcinomas.
92
 Patra et al. carried 
out the studies on methylation-demethylation enzymes activities in human 
prostate cancer for the first time.
93
 Their experimental results clearly 
demonstrated that the Dnmt1 MTase activity is upregulated, whereas the DNA 
demethylase, MBD2, is repressed at the level of translation in human prostate 
cancer.  
In addition, DNA MTases have been used as potential targets for therapy of 
epigenetic cancer.
94
 For example, researchers examined the prognostic and 
predictive impact of Dnmt1 and Dnmt3b expression in gastric carcinomas 
treated by neoadjuvant chemotherapy.
95
 Low Dnmt1 expression was observed 
for the patients treated with (platinum/5-fluorouracil)-based neoadjuvant 
chemotherapy.  Recently, increased Dnmt1 MTase activity and elevated 
methylation induced by epidermal growth factor receptor activation were 
investigated in ovarian cancer by Samudio-Ruiz.
96
 Treatment with the Dnmt1 
inhibitor agent 5-Aza-2'-deoxycytidine inhibited the epidermal growth factor 
induced increase of both DNMT activity and global methylation. These data 
support a role for epidermal growth factor receptor in the process of 
accumulated DNA methylation during ovarian cancer progression and suggest 
that epigenetic therapy may be beneficial for the treatment of ovarian cancer. 
In view of the essential roles of DNA methylation and DNA MTase in gene 
regulation, as well as their potentials to act as targets for cancer diagnosis and 
therapy, the development of DNA MTase activity biosensors is of paramount 
significance for both scientific research and clinical applications. Over the past 
decades, a number of methods have been reported for DNA MTase activity 
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measurement. The development history of various DNA MTase activity 
biosensors will be reviewed in the following section. 
1.3.3 Methods for the detection of DNA MTase activity  
 In 1992, Boye et al. reported the direct quantitation of Dam MTase in 
Escherichia coli by gel electrophoresis.
97
 After polyacrylamide gel 
electrophoresis, the amounts of Dam MTase in extracts of wild-type cells were 
measured by immunoblotting. Later on, various indirect detection methods 





were established. The DNA MTase activity was reflected on the radioactivity 
of the 
3
H incorporation into substrate DNA after methylation catalyzed by 
MTase. Before the radioactivity measurement by scintillation counting, 
various separation approaches of the methylated 
3
H incorporated substrate 
DNA from 
3












 etc. Alternatively, an indirect method that monitors the 
conversion of SAM to S-adenosyl-L-homocysteine (SAH) using liquid 
chromatography/mass spectrometry was applied to detect MTase activity.
103
 
These methods depend either on multiple-step protocols, radioisotopes, and/or 
expensive and demanding equipment. Thus, the development of simple, cost-
effective, robust biosensors for quantifying the activity of DNA MTase has 
drawn intensive attention in the past few years. The following two subsections 
review the reported MTase activity biosensors based on electrochemical and 
optical platforms which are the most commonly employed techniques in 
recently developed DNA MTase activity biosensors. 
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1.3.3.1 Electrochemical DNA MTase biosensors 
Most of the reported electrochemical DNA MTase biosensors use the 
restriction/modification system. Namely, the DNA MTase and methylation 
sensitive restriction endonuclease couples (Table 1.3) are employed. Generally, 
in these biosensors, the substrate DNA is firstly immobilized onto the 
electrode surface, the immobilized DNA is subsequently methylated by MTase, 
then the introduction of the endonuclease results in the amount changes of the 
electrochemical signal producer conjugated or absorbed onto the substrate 
DNA.  
Table 1.3. Typical DNA MTase and methylation sensitive restriction 
endonuclease couples.  
MTase Recognition site (5’-3’) Endonuclease Cleavage site 
Dam GATC DpnI 
 
Dnmt1 Hemimethylated CG BstUI 
 
M.SssI CG  HpaII 
 
 
Methylene blue is one of the most commonly used electroactive species for 
signal production.
104-107
 For example, Su et al. reported a signal-on 
electrochemical Dam MTase biosensor which was composed of a methylene 
blue modified signaling DNA probes and capture DNA probes tethered 
methylation-responsive hairpin DNA (hairpin-capture DNA probe). As 
illustrated in Figure 1.5, thiol-modified hairpin-capture DNA probes were 
firstly self-assembled on a gold electrode. Methylation induced scission of 
hairpin-capture DNA probes would displace the hairpin section and remain the 
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capture DNA probe section on the gold electrode. Subsequently, the remained 
capture DNA probes on the gold electrode can hybridize with the methylene 
blue modified signaling DNA probes, mediating methylene blue onto the gold 
electrode surface to a generate redox current. Apart from methylene blue, 
similar approaches were proposed by using other electroactive signal 











 Moreover, Wu and co-workers developed an 
electrochemical Dam MTase biosensor based on methylation sensitive 
cleavage using terminal transferase (TdTase)-mediated extension.
114
 In this 
biosensor, streptavidin-alkaline phosphatase, which catalyzes the conversion 
of electrochemically inactive 1-naphthyl phosphate into an electrochemically 
active phenol, was employed for the generation of an amplified 
electrochemical signal. 
 
Figure 1.5. Schematic representation of the electrochemical MTase sensor. 
Reproduced from reference 104 with permission. 
 
In addition to the above described methylation sensitive restriction 
endonuclease based MTase biosensors, Ai’s group investigated the 
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electrochemical immunosensors for MTase activity analysis.
115-119
 In their 
studies, either methyl binding domain proteins (MeCP2 and MBD) or anti-5-
methylcytosine antibody was used to recognize the methylated CpG sites in 
substrate DNA.  
     
1.3.3.2 Optical DNA MTase activity biosensors 
In 2005, Woo et al. proposed a nonradioactive optical biosensor for DNA 
MTase activity detection for the first time.
120
 In this biosnesor, double 
stranded-DNA (ds-DNA) substrates which were labeled with digoxigenin at 
one 3’ end and biotin at the other 3’ end were immobilized into a streptavidin 
coated microplate. After a subsequent treatment with MTase and restriction 
endonuclease, anti-digoxigenin-alkaline-phosphatase was introduced. Finally, 
alkaline-phosphate catalyzed the conversion of 1-nitrophenyl phosphate to 
phenol, and the absorbance was measured at 405 nm. Later on, new 
approaches based on DNA methylation induced aggregation-dispersion of 
DNA linked gold nanoparticles were established by several researchers.
121-123
 
Additionally, catalytic nucleic acids of DNAzyme which exhibit horseradish 
peroxidase (HRP) mimicking properties were incorporated into DNA 
substrates for DNA MTase activity monitoring.
124-126
 The MTase 
methylation/endonuclease cleavage events were correlated with the 
DNAzymes formed after dissociation from the substrate DNAs. DNAzyme 
can catalyze the oxidation of 2,2’-azino-bis(3-ethylbenzothiazoline)-6-
sulfonate disodium salt by H2O2 to produce colored radical ions, thereby 
causing a detectable color change. 
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On the other hand, Leonhardt’s group developed fluorescence-based 
trapping biosensors for Dnmt1 activity analysis.
127, 128 
Both biosensors used 
transiently expressed green fluorescent protein fused Dnmt1 (GFP-Dnmt1) 
and MTase inhibitors such as 5-azacytidine and 5-aza-2’-deoxycytidine. These 
nucleotide analogues were incorporated into the newly synthesized DNA at 
nuclear replication sites and caused irreversible immobilization, namely, 
trapping of GFP-Dnmt1 fusions at these sites. Although these biosensors 
allowed direct visualization of Dnmt1 activity in living cells in high 
throughput, the GFP-Dnmt1 and synthetic oligonucleotides preparation 
processes were very rigorous and tedious.  
Recently, various novel strategies based on simply fluorophore-labeled 
DNAs have been developed. For example, a hairpin substrate DNA was 
modified with a fluorophore and a quencher at its 5’ and 3’ end, respectively. 
DNA methylation and cleavage by the MTase/endonuclease couple would 
cause the separation of the fluorophore and the quencher, resulting in the 
restoration of the fluorescence.
129, 130
 Alternatively, other than the direct 
modification of substrate DNA, fluorophore and quencher linked molecular 
beacons were utilized for signal amplification.
131-135
 In those biosensors, the 
nucleic acid strands dissociated from MTase substrate DNAs after 
methylation/cleavage would hybridize with the molecular beacons, then the 
following cleavage or opening the hairpin structure of the molecular beacons 
resulted the restoration of their fluorescence. In addition, due to the rapid 





 and gold nanorods
139
 were employed as 
fluorescence quenchers for MTase activity detection. 
 24 
 
As can be seen from the review of MTase activity biosensors described 
above, the development of various MTase activity biosensors are mainly 
reported in the last ten years, indicating that it is a relatively new biosensing 
area targeted at MTases. Thus, further attempts to establish novel MTase 
activity biosensors are highly desired.  
                         
1.4 Objectives and significance of the studies 
The purposes of the studies involved in this thesis are: 
 To synthesize an anionic Os-based redox polymer and use it as an electron 
mediator for interference-free glucose detection. 
 To synthesize a low working potential Ru-based redox polymer and use it 
as an electron mediator for interference-free glucose detection. 
 To prepare lamellar-ridge architectured gold by using butterfly wings as 
the template and use it for nonenzymatic glucose detection. 
 To synthesize a PIND-Os duplex DNA intercalator and use its 
elecrocatalytic oxidation of ascorbic acid as the signal producer and 
amplifier for sensitive DNA MTase activity detection. 
 To prepare two dimensional (2D) MoS2 nanosheets and extend their 
application in a fluorescent DNA MTase activity biosensor as an efficient 
fluorescence quencher. 




Through these studies, we have obtained the following achievements 
successfully: 
 By using the two kinds of redox polymers listed above, the interference 
problems resulting from the commonly encountered coexisting species in 
blood in electrochemical glucose biosensors have been successfully 
avoided. The excellent anti-interference capability of the two proposed 
glucose biosensors are attributed to the unique properties of the redox 
polymers. This may give more options for mediators used for reliable 
glucose biosensing.  
 By using the gold samples with lamellar-ridge architecture templated by 
butterfly wings, a nonenzymatic glucose biosensor with outstanding 
performance has been fabricated. This presents an exemplary strategy of 
using the vast configuration pool from nature to blueprint the structural 
design of efficient electrochemical biosensors. 
 By using the PIND-Os intercalator, MoS2 nanosheets, and the PGM, three 
novel DNA MTase activity biosensors have been successfully developed. 
This may serve as potential DNA MTase activity biosensor candidates in 
clinical diagnosis applications. 
 
1.5 Scope and overview of the thesis 
Due to the restriction of accessing real blood samples in Singapore, a 
commercially available control solution (synthetic blood from Roche 
Diagnostics) for glucose meters which essentially contains the basic 
components that mimic human blood was employed to verify the reliability of 
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the newly developed glucose biosensor for routine analysis. The MTase 
models chosen in the studies on MTase activity biosensors are restricted to 
those MTases from bacteria since they are easy to obtain and there is no need 
of hemi-methylation modification of their substrate DNA. Subsequently, there 
is no real sample analysis performed for the MTase activity biosensors 
developed in the thesis.  
This thesis centers on two targets, glucose and DNA MTase. The studies 
presented in Chapter 2, Chapter 3, and Chapter 4 aim on the glucose detection. 
The studies presented in Chapter 5 and Chapter 6 aim on the DNA MTase 
activity biosensors. Chapter 7 links glucose with DNA MTase by employing a 
personal glucose meter as the signal readout for the detection of DNA MTase 
activity. The diagrammatic representation of the outline of this dissertation is 
illustrated in Figure 1.6. 
 




The details of each study involved in the thesis, such as experimental 
methods, results and discussion, and conclusions, are presented separately in 
the following six chapters. Chapter 2 describes the glucose biosensor using a 
synthetic anionic Os-based redox polymer as the mediator to eliminate 
interference based on the electrostatic repulsion between the mediator and the 
interferants.  
In Chapter 3, a ruthenium complex-based low-potential redox polymer (Ru-
RP) was prepared and characterized by FT-IR, UV-vis spectrometry and gel 
permeation chromatography. Then the experimental conditions were 
optimized for the Ru-RP mediated glucose biosensor. Under the optimal 
experimental conditions, the developed biosensor showed good analytical 
performance and excellent anti-interference ability toward AA, UA, and DA 
due mainly to its very low operation potential. Finally, real sample analyses 
were performed to verify the reliability of the biosensor. 
In Chapter 4, gold samples with lamellar-ridge architecture templated by 
blue scales from Morph butterfly wings were prepared by using an electroless 
deposition method. The as-prepared gold samples were characterized by SEM, 
XRD, XPS, and TGA. Then the gold material was used to construct an 
amperometric glucose biosensor. The excellent analytical performance of the 
biosensor, which was originated from the unique architecture of the gold 
samples, was demonstrated.  
Chapter 5 explores an electrochemical M.SssI MTase activity biosensor, 
which employed a synthetic intercalator PIND-Os catalyzed ascorbic acid 
electro-oxidation reaction as the signal producer. Each step of modification on 
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the working electrode was monitored by electrochemical impedance 
spectroscopy (EIS) and differential pulse voltammetry (DPV). Attributing to 
the catalytic signal amplification, high sensitivity was achieved. The anti-
interference and inhibitor screening abilities of the MTase activity biosensor 
were also demonstrated.  
Chapter 6 investigates a fluorescent Dam MTase activity biosensor which 
employed a newly emerging two dimensional transition metal dichalcogenides, 
MoS2 nanosheets, as the fluorescence quencher. The MoS2 nanosheets were 
firstly prepared by mixed solvent exfoliation, and then characterized by atomic 
force microscopy (AFM) and UV-vis spectrometry. The fluorescence 
quenching mechanism and the feasibility of MTase activity sensing were 
carefully studied. Finally, the calibration study, interference study, and the 
inhibitor screening study were conducted. 
In Chapter 7, a personal glucose meter was adapted to detect M.SssI MTase 
activity. The substrate DNA of M.SssI MTase was firstly conjugated with 
invertase which catalyzes the hydrolysis of sucrose to glucose and fructose, 
and the conjugates were characterized by gel imaging. The invertase-DNA 
conjugates were immobilized onto magnetic beads via streptavidin-biotin 
interaction. The experimental conditions including methylation time and 
cleavage time were optimized. Under the optimal conditions, calibration study, 




Chapter 2. An interference-free glucose biosensor 
based on an anionic redox polymer-mediated 
enzymatic oxidation of glucose 
 
2.1 Introduction 
In this work, an amperometric biosensor based on immobilized GOx and an 
Os(bpy)2 (bpy=2,2’-bipyridine)-based anionic redox polymer (Os-RP) 
mediator was developed for the determination of glucose. GOx and the water-
soluble crosslinkable Os-RP were co-immobilized on a glassy carbon 
electrode (GCE) in one step by employing glutaraldehyde as a crosslinker. In 
addition to its excellent electrocatalytic power, the crosslinked membrane 
acted as a thin permselective polymeric membrane with excellent selectivity 
for glucose over interferants such as ascorbic and uric acid. The interferant-
eliminating property was obtained through the presence of a large number of 
sulfonic acid groups in the redox polymer. In addition, the high hydrophilic 
nature of the membrane effectively retarded the diffusion of molecular oxygen. 
This biosensor showed high sensitivity and excellent selectivity for glucose 
over interferants such as molecular oxygen, ascorbic acid, and uric acid. 
 
2.2 Experimental 
2.2.1 Materials and apparatus 
GOx, (EC 1.1.3.4, from Aspergillus niger, 191 units mg
-1
) was purchased 
from Fluka (CH-9407 Buchs, Switzerland). Glucose, glutaraldehyde (25 %), 
ascorbic acid, and uric acid were obtained from Sigma–Aldrich (St. Luis, MO, 
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USA). All other reagents were of analytical grade and used without further 
purification. Ultrapure deionized water with an electric resistance of 18.3 MΩ 
was used for all solution preparations. Glucose stock solutions were allowed to 
mutarotate for 24 h before use. Freshly prepared ascorbic acid and uric acid 
solutions were used in the interference study. PBS was used as the supporting 
electrolyte and was prepared weekly using deionized water. [Os(bpy)2Cl2] was 
synthesized from (NH4)2OsCl6 by the procedure developed by Lay and 
coworkers.
140
 The water-soluble and crosslinkable Os-RP (Scheme 2.1), 
poly(4-vinylimidazole-coacrylamide-co-2-acrylanmido-2-
methylpropanesulfonic acid) partially complexed with [Os(bpy)2Cl]
+
, was 
synthesized following a previously reported procedure.
141
 Spectroscopic and 
elemental analysis showed that the synthesized redox polymer, on average, 
consisted of 16 [Os(bpy)2Cl]
+
, 18 amide, and 66 sulfonic acid moieties. 
 
Scheme 2.1. Structure of the Os-RP. 
 
Electrochemical experiments were carried out on a CHI760D 
electrochemical workstation (CH instruments, Austin, Texas). A conventional 
three-electrode system, consisting of the GCE working electrode, an Ag/AgCl 
(saturated KCl) reference electrode, and a platinum wire counter electrode, 
was employed. All potentials reported in this work were referred to the 
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Ag/AgCl reference electrode. Cyclic voltammetric tests of the biosensor were 
performed at a potential scan rate of 50 mV s
-1
 in a potential window between 
-0.20 and 0.60 V. In amperometry, the background current was allowed to 
stabilize first before readings were taken. Small aliquots of glucose stock 
solution were added sequentially to reach the desired glucose concentrations in 
the test solutions. 
 
2.2.2 Glucose Biosensor Fabrication 
As for the biosensor fabrication, the GCE was first polished on a microcloth 
with 0.05 m alumina slurry, followed by sonication in ultrapure water and 
ethanol for 5 min, successively. After drying the cleaned electrode, 4 L of a 
mixed solution consisted of GOx, Os-RP, and glutaraldehyde was applied onto 
the GCE surface. The GCE was then incubated for at least 12 h under ambient 
conditions. During incubation Os-RP/and GOx were irreversibly crosslinked, 
forming the desired glucose sensing membrane on the GCE. The biosensor 
was kept at 4 °C when not in use. Little activity loss was observed within six 
months of storage. 
 
2.3. Results and discussion 
2.3.1 Electrochemical Characteristics of the Biosensor 
In the absence of glucose, cyclic voltammetric tests of the biosensor in 
phosphate-buffered saline solution (PBS) (pH 7.4, 0.15 M NaCl, 20 mM 
phosphate) showed a pair of well-defined current peaks that were assigned to 
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embedded in the Os-RP/GOx membrane.
142
 The charge under either the 
oxidation or the reduction current peak indicated the amount of the redox 
polymer deposited on the GCE surface (Figure 2.1, trace 1). Moreover, the 
magnitudes of the anodic and cathodic peak current were practically the same 
and the peak-to-peak potential separation was ~60 mV, close to the theoretical 
value of 59 mV at 25 °C. This implies that the electron exchange process 
between the redox polymer and the substrate GCE is rapid and the electron-
mediating power of the redox polymer is excellent. The electrode process is 
diffusion-controlled
143
 due to the relatively thick membrane on the electrode 
surface,
144
 which means that in this case the diffusion of the glucose substrate 
will be the rate determining step. It can also be inferred from the cyclic 
voltammogram of the Os-RP/GOx membrane that GOx in the membrane does 




 redox couple. 
 
Figure 2.1. Cyclic voltammograms of the Os-RP/GOx/GCE biosensor (1) in 
the absence and (2) presence of 10 mM glucose. Supporting electrolyte: PBS, 




On the other hand, as depicted by trace 2 of Figure 2.1, in the presence of 
glucose the cyclic voltammogram became sinusoidal with a greatly increased 
oxidation current and a severely diminished reduction current—a typical 
electrocatalytic voltammogram,
145
 resulting from the Os-RP-mediated glucose 
oxidation by GOx. Supportive evidence was found from the low hysteresis of 
the voltammogram between the oxidation and reduction branches. The 
absence of the reduction current peak in the cyclic voltammogram implies that 
the Os-RP/GOx membrane is homogenously maintained in the reduced state 
by the excellent electron relaying power of the redox polymer in the 
membrane through the transfer of electrons from the reduced GOx to the 
oxidized Os-RP (Os
3+





 moieties in the Os-RP/GOx membrane act as artificial electron 
donors in the place of molecular oxygen for GOx and electron shuttles 
between GOx and the substrate GCE. As illustrated in Figure 2.2, glucose in 
solution is first enzymatically oxidized to gluconolactone, leaving behind two 
electrons. Meanwhile, the redox center (FAD) of GOx receives the two 
electrons returning to its reduced state. The electrooxidized Os-RP (Os
3+
) then 
reacts with the reduced GOx, accepting the aforementioned electrons from the 
reduced GOx to become reduced (Os
2+
) and regenerating the oxidized GOx. 
The reduced Os-RP then gives up its electrons to the substrate GCE, 
generating a current while Os
2+
 returns back to its oxidized state Os
3+
. Since 





 couple in the redox polymer and as there are plenty of Os
3+
 
ions in the vicinity of the redox centers of GOx, the electron transfer between 
Os
3+
 and the reduced GOx is kinetically rapid, consuming all Os
3+
 moieties in 
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the membrane as soon as they are formed. The oxidation current is now 
controlled by either the diffusion of glucose or by the kinetics of the 
enzymatic oxidation of glucose, depending on the concentration of glucose. 
For the amperometric determination of glucose, in order to maximize the 
sensitivity of the biosensor, to minimize background current, and to eliminate 
possible interferences from oxidizable species, the potential should be poised 
on the anodic side of the current peak and in the vicinity of the peak potential. 
So in this case, 0.25 V was chosen as the voltammogram peaked off at ~0.22 
V. The time needed to reach 90% of the maximum response (response time) in 
amperometry at 0. 25 V was within 5 s. 
 
Figure 2.2. Working principle of the Os-RP-mediated glucose sensing process. 
  
2.3.2 Optimization 
The above results confirmed that Os-RP-mediated enzymatic oxidation of 
glucose is successfully achieved at the proposed biosensor with sufficient 
sensitivity. In the case of electrocatalytic oxidation of glucose, the oxidation 
current must be determined by one or a combination of the following 
processes: 1) mass-transport of glucose, 2) GOx-catalyzed oxidation of 
glucose at the biosensor–solution interface and within the membrane, and 3) 
the electron-mediating power of the redox polymer.
146
 However, for a 
successful adaptation of the biosensor in the quantification of glucose, the 
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oxidation current must be exclusively associated with the concentration of 
glucose in a straightforward manner, preferably a linear correlation between 
the oxidation current and the glucose concentration. This solely glucose-
controlled process can only be achieved by speeding up the electron-mediating 
power and the enzymatic oxidation process. High electron-mediating power is 
easily attainable when working with a high concentration of the redox polymer 
in the membrane and high enzymatic reaction rate is achievable by increasing 
the loading of GOx in the membrane. 
 
Figure 2.3. The effect of (a) Os-RP loading and (b) GOx loading on the 
amperometric response of 10 mM glucose. Supporting electrolyte: PBS, 
poised potential: 0.25 V. 
 
The effect of Os-RP loading on the performance of the biosensor was first 
evaluated and the results were summarized in Figure 2.3a. The loading mass 
of GOx and GA both were fixed, the loading amount of Os-RP was evaluated 
from 0.1 to 0.6 g. As seen in Figure 2.3a, as the redox polymer loading in the 
membrane was increased, the oxidation current of glucose rose rapidly at first, 
but then leveled off at ~0.50 g. It was observed that the oxidation current of 
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glucose is practically independent of the redox polymer loading beyond 0.50 
g, suggesting that the mediating power of Os-RP reaches its maximum at this 
quantity. In addition to the detrimental effect on the background current, too 
high an Os-RP loading may also adversely affect its mediating power. 
Therefore, 0.50 g Os-RP was chosen for all subsequent experiments. The 
oxidation current of glucose is now determined by either the enzymatic 
oxidation or the diffusion of glucose. Figure 3b describes the dependence of 
the oxidation current of glucose on the loading of GOx in the Os-RP/GOx 
membrane. As anticipated, the GOx loading had a profound effect on the 
oxidation current of glucose. 
The loading mass of Os-RP and GA were both fixed, the loading amount of 
GOx was evaluated from 10 to 100 g. As illustrated in Figure 2.3b, when the 
GOx loading was increased from 10 to 50 g, the oxidation current increased 
sharply, due to the increase in the enzymatic oxidation rate, because the 
reaction rate of a catalytic process generally scales up with the catalyst, GOx 
in this case. The highest current was attained when 50 g of GOx was loaded 
on the biosensor. A further increase in GOx loading did not result in any 
appreciable increase in the oxidation current. On the contrary, being a natural 
insulator, it was found that the oxidation current decreases when an excessive 
amount of GOx was loaded. For example, a ~50% drop in the oxidation 
current was observed when 100 g of GOx was loaded onto the biosensor, 
probably due to a drastically reduced electron exchange rate between the Os-
RP/GOx membrane and the substrate GCE, since GOx itself does not 
exchange electrons with the substrate electrode. On the contrary, the presence 
of the large excess of GOx in the membrane severely impedes (blocks) the 
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electron exchange pathways between the redox polymer and the substrate 
GCE. Therefore, the amount of GOx loaded onto the biosensor was fixed at 50 
g to ensure sufficiently high sensitivity and good signal-to-noise ratios. 
 
2.3.3 Analytical Performance of the Biosensor 
The performance of the proposed biosensor was investigated through a 
calibration and interference study. The correlation between the amperometric 
response and glucose concentration was studied in a series of glucose 
solutions in PBS under optimized experimental conditions. The interference 
study was carried out in PBS that contained 5 mM glucose, 0.1 mM ascorbic 





Figure 2.4. Calibration curve of the Os-RP/GOx/GCE glucose biosensor. 




Under the optimized experimental conditions, a linear correlation between 
the oxidation current in amperometry and the glucose concentration was found 
between 0 and 10 mM at the Os-RP/GOx/GCE glucose biosensor with a 
correlation coefficient (R
2





 (Figure 2.4). In this concentration range, glucose is the limiting 
factor in the reaction and GOx is in excess. Above 10 mM the current 
increased at a much lower rate and it eventually started to level off beyond 15 
mM. As all the active sites on the enzyme were fully saturated and operating 
at a maximum speed at 40 mM, any further increase in glucose concentration 
beyond 40 mM did not appreciably increase the catalytic oxidation current. 
 
Figure 2.5. Normalized amperometric responses of 5 mM glucose, 5 mM 
glucose + 0.1 mM AA, 5 mM glucose + 0.2 mM UA and 5 mM glucose + 0.1 
mM AA + 0.2 mM UA, respectively. Supporting electrolyte: PBS, poised 
potential: 0.25 V. 
 
Because of their low redox potentials,
148, 149 
ascorbic acid and uric acid are 
the common redox active interferants in blood when detecting blood glucose 
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using the amperometric method. In the absence of an analyte-regulating 
mechanism, the electrochemical oxidations of anionic ascorbic acid and uric 
acid were disproportionately high since the redox polymer used was usually 
polycationic.
150, 151
 This is due to the accumulation of anionic interferants 
within the redox polymer scaling with the density of cationic sites. The 
introduction of a high density of sulfonic acid groups into the redox polymer is 
expected to result in a marked improvement of the performance of the 
biosensor in terms of selectivity. To confirm this hypothesis, the anti-
interference ability of the proposed glucose biosensor was studied in a 5 mM 
glucose solution in the presence of 0.1 mM AA and 0.2 mM UA. As shown in 
Figure 2.5, the presence of AA and UA contributed less than 5% to the overall 
oxidation current. This is mainly due to the presence of a high density of 
anionic sulfonic acid groups in the redox polymer. Strong electrostatic 
repulsion between sulfonic acid groups and the AA and UA greatly suppress 
the access of these anionic species to the biosensor. 
As mentioned earlier, depending on the kinetics of the mediated glucose 
oxidation, dissolved molecular oxygen may affect the sensitivity of the 
biosensor. In the proposed biosensor, the introduction of the high density of 
anionic sulfonic acid moieties in the redox polymer made the Os-RP/GOx 
membrane highly hydrophilic, which efficiently facilitates electron transfer 
and effectively suppresses the transport of molecular oxygen as molecular 
oxygen is largely hydrophobic, granting the biosensor good insensitivity to 
dissolved molecular oxygen. Indeed, a difference smaller than 2% was 
observed between the amperometric responses of 5.0 mM glucose solution 
before and after thorough purging with nitrogen. The engagement of the 
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anionic redox polymer in the construction of the glucose biosensor allows 
glucose to be selectively determined by the biosensor at its maximal 
sensitivity. In practice, this level of selectivity satisfactorily meets the 
requirement for the quantification of glucose in human blood samples. The 
only drawback of this biosensor was the relatively low mechanic strength. 
 
2.4. Conclusion 
In this work, an enzymatic amperometric glucose biosensor was fabricated 
by using an anionic Os(bpy)2-based redox polymer as a mediator. The 
analytical signal of the biosensor was directly generated from the catalytic 
oxidation of glucose in the sample. This contributes to the high sensitivity of 
this biosensor and sets it apart from other glucose sensors that relying on 
indirect measurements of glucose through dissolved molecular oxygen or 
hydrogen peroxide. A linear dynamic range between 0 and 10 mM glucose 
with excellent sensitivity was obtained. More notably, the biosensor showed 
high anti-interference ability. Practically no interference from the common 
coexisting species such as dissolved molecular oxygen, ascorbic acid, and uric 
acid were observed. As compared to other approaches, the much enhanced 
selectivity and sensitivity are attractive features for further study, particularly 




Chapter 3. An interference-free glucose biosensor 
based on a novel low potential redox polymer mediator 
 
3.1 Introduction 
As mentioned in Section 1.2.3.2, one of the strategies to eliminate 
interferences from the mediated oxidation of glucose is to operate the glucose 
biosensor at a low enough applied potential so as not to provoke interfering 
reactions from the interferants. Using this strategy, Nam and co-workers 
showed that when [Ru(NH3)6]
3+ 
was used as the mediator, it allowed the use of 
a relatively low applied potential of 0.0 V(vs. Ag/AgCl) and could effectively 
eliminate interferences from AA, DA, UA, and AMP.
76
 Following this 
argument, if one could design a mediator-based glucose biosensor which 
operates at even lower applied potential, the contribution to the oxidation 
current from undesirable interferants can be further reduced or may even be 
completely eliminated.  
In this report, the feasibility of developing an interference-free 
amperometric glucose biosensor which can mediate enzymatic oxidation of 
glucose at a considerably low potential was investigated. A novel water-
soluble and crosslinkable ruthenium complex-tethered redox polymer (Ru-RP) 
was first successfully synthesized. Excellent electron mediating power 
between GOx and substrate electrode at -0.15 V (vs. Ag/AgCl) was observed 
when the Ru-RP was crosslinked with GOx on a glassy carbon electrode 
(GCE). In addition to its high sensitivity and fast response time, the biosensor 
was practically immune to all potential interferants commonly encountered in 
glucose monitoring. This superior interference-free property was achieved 
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through the use of an ultralow applied potential which would not provoke 
interferences from other easily oxidizable species. Moreover, the excellent 
mediating power of the Ru-RP and the hydrophilic nature of the membrane 
also effectively retarded the interference from molecular oxygen. 
 
3.2 Experimental 
3.2.1 Reagents and appratus 
GOx (EC 1.1.3.4, from Aspergilus niger, 191 units mg
-1
) was purchased 
from Fluka (CH-9407 Buchs, Switzerland). Hexaammineruthenium(III) 
chloride [Ru(NH3)6Cl3] was from Strem Chemicals (Newburyport, MA, USA). 
All other chemicals of certified analytical grade were obtained from Sigma-
Aldrich (St. Louis, MO, USA) and used without further purification. Glucose 
stock solutions were allowed to mutarotate for 24 h before use. Freshly 
prepared AA, DA, UA, and AMP solutions were used in the interference study. 
All electrochemical studies were carried out in pH 7.4 PBS (20 mM phosphate, 
0.15 M NaCl). All aqueous solutions were prepared with ultrapure deionized 
water (18.3 ΩM). 
Electrochemical measurements were performed with a CHI650D 
electrochemical workstation (CH Instruments, Austin, Texas). A conventional 
three-electrode system comprising a GCE (3 mm in diameter) working 
electrode, an Ag/AgCl reference electrode, and a platinum wire counter 
electrode, was employed in all electrochemical experiments. All potentials 
reported in this work were referred to the Ag/AgCl reference electrode. 
Electrochemical impedance experiments were conducted with an IM6 
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electrochemical workstation (Zahner Elektrik, Germany). UV-vis spectra were 
recorded on an Agilent Cary 60 UV-vis spectrophotometer (Agilent 
Technologies, Palo Alto, CA, USA). Molecular weight was determined 
through high performance gel permeation chromatography (GPC) in water and 
standard poly (ethylene oxide) was used for calibration. 
  
3.2.2. Preparation of the redox polymer 
The copolymer backbone [poly (vinylpyridine-co-acrylamide), PVPAA] 
was synthesized according to a published procedure.
152
 The Ru-RP was 
prepared according to the following procedure: 50 mg of PVPAA and 50 mg 
of Ru(NH3)6Cl3 were dissolved in 4 mL of mixture solvent (ethylene 
glycol:water 1:1, v/v). The mixture was refluxed for 3 h at 80-90°C. Upon 
cooling, the reaction mixture was centrifuged. To a rapidly stirred acetone, the 
supernatant was added drop-wise to precipitate the redox polymer. Further 
purification was carried out by treating the precipitated redox polymer with 
multiple water-dissolving acetone-precipitating cycles. The purified product 
was then dried under vacuum at 50°C. Typical yields were between 55 and 
90%. 
  
3.2.3. Preparation of the biosensor 
A GCE was polished on a microcloth with 0.3 and 0.05 m alumina slurry 
sequentially and sonicated for 5 min in water and ethanol between each 
polishing step. Upon drying, 5 L of a mixed solution containing 3 L Ru-RP, 
1 L GOx, and 1 L glutaraldehyde (GA) was applied onto the cleaned 
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electrode. The electrode was kept under ambient conditions for at least 12 h. 
During this period of time, an irreversible crosslinking reaction took place and 
formed the desired glucose sensing membrane on the GCE. The glucose 
biosensor was stored at 4°C when not in use. 
 
3.3 Results and discussion 
3.3.1. Synthesis and characterization of the Ru-RP 
As depicted in Figure 3.1A, vinylpyridine in the copolymer affords the 
availability of the pyridine ring which allows subsequent N-coordination with 
the redox active ruthenium complex; while acrylamide offers good chemical 
and mechanical stability and resistance to microbial degradation and serves as 
a support matrix.
153
 The amide group present in acrylamide also allows 
chemical crosslinking with GA to enhance the stability of the enzyme in the 
glucose sensing membrane. Figure 3.1B shows the synthesis route for the Ru-
RP. Results from GPC showed a monomodal elution peak for the Ru-RP. This 
provided the first hint of a successful synthesis and that Ru-RP was a 
copolymer rather than blends of two homopolymers. The weight-average 
molecular weight (Mw) of the redox polymer was found to be 53,200 and the 
polydispersity index (PDI) was 1.56. Ruthenium loading in the Ru-RP, 
determined from elemental analysis, was found to be ∼14%. To further 
confirm the formation of the Ru-RP, FT-IR and UV-vis experiments were 
carried out. As shown in Figure 3.2A, the FT-IR spectrum of the Ru-RP 
clearly showed the complete disappearance of vinyl absorption at 1650 cm
-1
 
and this suggests that the vinyl monomers were successfully polymerized and 
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the resulting redox polymer was of high purity and free of monomers. Further 
evidence can be found in the 400-500 cm
-1
 region. The weak absorption at 444 
cm
-1
 indicates the presence of ruthenium-pyridine bond in the Ru-RP. This 
absorption peak is in addition to the pyridine-ammine absorption peak at 466 
cm
-1
 found in the FT-IR spectra of both the Ru-RP and Ru(NH3)6Cl3. UV-vis 
spectra (Figure 3.2B), again, confirmed the successful synthesis of the Ru-RP. 
Firstly, the UV-vis spectrum of the Ru-RP indicates that it is not a simple 
blend of its two starting materials, PVPAA and Ru(NH3)6Cl3. Secondly, the 
UV-vis spectrum of the Ru-RP displays a more intense d → π* metal-to-
ligand charge-transfer (MLCT) band associated with the pyridine ring at 540 
nm and a less intense intraligand, π → π*, electronic transition at 375 nm and 
both of which are consistent with the proposed structure of the Ru-RP. 
 
Figure 3.1. (A) Reaction scheme of the PVPAA backbone. (B) Synthetic route 





Figure 3.2. (A) The FT-IR spectrum of the Ru-RP. (B) UV-vis spectra of the 
Ru-RP, PVPAA, Ru(NH3)6Cl3, and PVPAA + Ru(NH3)6Cl3. 
 
3.3.2. Electrochemical characteristics of the biosensor 
The operating principle of the biosensor is based on the enzymatic oxidation 
of glucose catalyzed by GOx (Figure 3.3). Due to the presence of GOx, 
glucose in solution is first enzymatically oxidized to gluconolactone and 
leaving behind two electrons. These two electrons are accepted by the redox 
center (FAD) of GOx to return to its reduced state. The electro-oxidized Ru-
RP (Ru
3+
) then reacts with the reduced GOx and accepts the aforementioned 
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electrons to become electroreduced Ru-RP (Ru
2+
) and regenerating the 
oxidized GOx. Finally, the electrons are transferred from Ru
2+
 to the substrate 
GCE and an oxidation current is generated when Ru
2+





Figure 3.3. Schematic illustration of the working principle of the glucose 
biosensor. 
 
Figure 3.4 trace 2 presents the cyclic voltammogram of the biosensor in 
PBS in the absence of glucose. A pair of well-defined current peaks which 





 of the Ru-RP. It can be further 
observed that due to the successful attachment of the copolymer backbone 
(PVPAA), Ru-RP displayed a noticeably different electrochemical behavior 
from that of its starting material, Ru(NH3)6Cl3, since a pair of reversible 
voltammetric peaks which centered at -0.14 V were obtained for the latter 
instead (Figure 3.4 trace 1). In addition, since the magnitudes of the anodic 
and cathodic peak currents for Ru-RP were similar and their peak-to-peak 
potential separation was close to the theoretical value of 59 mV at 25°C, this 
provided further evidence that the electron transfer process between the Ru-
RP/GOx membrane and the substrate electrode is rapid and diffusion-
controlled.
143
 This is most likely due to the relatively thick membrane coated 
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on the electrode surface.
144
 Based on the rapid kinetics and symmetry of the 
reduction and oxidation peaks, it could also be inferred that GOx does not 




 redox couple in the Ru-
RP/GOx membrane.  
 
Figure 3.4. Cyclic voltammograms of (1) Ru(NH3)6Cl3, and a glucose 
biosensor in the absence (2)  and presence (3) of 8 mM glucose. Supporting 
electrolyte: PBS, potential scan rate: 50 mV/s. 
 
When glucose was added to the PBS, a typical sinusoidal electrocatalytic 
cyclic voltammogram (Figure 3.4 trace 3) was observed with a greatly 
increased oxidation current and a severely diminished reduction current. The 
absence of the reduction current peak in the voltammogram implies that at a 
scan rate of 50 mV s
-1
, the glucose sensing layer is homogeneously maintained 
in the reduced state by the rapid electron transfer from the reduced GOx to the 
oxidized Ru-RP (Ru
3+





moieties in the Ru-RP/GOx membrane could serve as artificial electrons 
donors and compete effectively with molecular oxygen in the oxidation of 
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glucose by rapidly shuttling electrons between GOx and the substrate 
electrode to generate a current signal.  
For amperometric determination of glucose, the choice of the applied 
potential has to be a compromise between sensitivity and selectivity. While 
increasing the applied potential increases the driving force between the 
enzyme and the mediator which subsequently increases the current density and 
sensitivity, it has to be noted that the applied potential has to be decreased in 
order to maximize selectivity by minimizing the current contribution from the 
oxidation of endogenous species such as AA, DA, UA, and AMP. Therefore, 
the applied potential has to be poised on the anodic side of the current peak 
and in the vicinity of the peak potential in order to strike the right balance 
between sensitivity and selectivity. Considering all of the above, the applied 
potential for all amperometric measurements was poised at -0.15 V (vs. 
Ag/AgCl) as the voltammogram peaking off from approximately -0.20 V 
onwards. The response time, which is the time required to reach 90% of the 
maximum response, was found to be within 10 s. 
The proposed biosensor was characterized by electrochemical impedance 
spectroscopy (EIS). A semicircle was observed for bare GCE, as shown in the 
Nyquist plots in Figure 3.5. The diameter of the semicircle slightly diminished 
for the GCE that modified with the glucose sensing membrane. Fitting results 
showed that the charge transfer resistance (Rct) of the bare GCE and modified 
GCE were 792.9 Ω and 719.6 Ω, respectively. Thus, the crosslinked sensing 
membrane did not retard the electron transfer between the redox centers of the 




Figure 3.5. Nyquist plots of a bare GCE and a modified GCE. Inset: Randles 
equivalent circuit. 
 
3.3.3. Optimization of the biosensor 
Since the proposed biosensor system capitalized on the catalytic reaction 
between the Ru-RP and GOx, for a successful application in glucose 
monitoring, the oxidation current has to be associated with the concentration 
of glucose in a straightforward manner. This implies a simple linear 
relationship between glucose concentration and oxidation current is sought 
and that the loading amount of the Ru-RP and GOx must be sufficiently large. 
Since GOx is immobilized on the GCE through chemical crosslinking between 
GOx and the Ru-PR by GA. Certainly, GA also plays an important role in 
achieving an optimum immobilized membrane on the electrode surface with 
maximum catalytic efficiency. Therefore, in order to enhance the performance 





Figure 3.6. The effect of (A) the Ru-RP, (B) GOx, and (C) GA loading on the 
amperometric response of 10 mM glucose. Supporting electrolyte: PBS, 
poised potential: -0.15 V. 
 
The effect of the Ru-RP loading on the response was first studied in the 
range of 12-30 g (Figure 3.6A). Meanwhile, the loading amount of GOx was 
fixed at 50 g, and GA 1.25% (w/v). The current response increased with 
increasing Ru-RP loading from 12 to 24 g. The response reached a maximum 
at 24 g and then decreased when the loading amount of Ru-RP was higher 
than 24 g. This suggested that the mediating power of the Ru-RP has reached 
its maximum at 24 g and further increase in the Ru-RP loading could 
adversely affect the membrane permeability for both glucose and 
gluconolactone. Therefore, 24 g of the Ru-RP was chosen in the following 
experiments in order to maximize the sensitivity of the biosensor.  
The dependence of the oxidation current on the loading of GOx is shown in 
Figure 3.6B. In this case, Ru-RP was fixed at its optimal value 24 g, and GA 
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1.25% (w/v). The highest response current was observed when 90 g GOx 
was loaded in the membrane and further increase of GOx loading even 
decrease the oxidation current. This could be due to the insulating nature of 
the enzyme which reduces the electron exchange rate between the sensing 
membrane and the substrate GCE and impedes the electron exchange 
pathways between the Ru-RP and the substrate GCE when excess amounts of 
GOx are loaded onto the GCE.  
Finally, the concentration of the GA was investigated and the results are 
depicted in Figure 3.6C by fixing the loading amount of Ru-RP and GOx to 24 
g and 90 g, respectively. The oxidation current increased with an increase 
of GA loading and reached a maximum at 1.5% (w/v) GA. Thereafter, further 
increase in GA loading beyond 1.5% resulted in a decrease in the oxidation 
current resulting from the increased diffusion resistance caused by excessive 
crosslinking. In addition, when excess amounts of GA were loaded onto the 
electrode, the activity of GOx was also adversely affected due to excessive 
crosslinking. 
 
3.3.4. Analytical performance of the biosensor 
The analytical performance of the biosensor was evaluated through 
calibration and interference studies. It was found that under the optimized 
experimental conditions, the oxidation cur-rent in amperometry at -0.15 V 
gave a good linear correlation (R
2
= 0.9962) with glucose concentration from 0 
to 10 mM and with a sensitivity of 24.3 A mM-1cm-2 (Figure 3.7A). In this 
concentration range, glucose was the limiting factor in the reaction while GOx 
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existed in a large excess and a simple linear relation-ship between glucose 
concentration and the oxidation current was achieved. However, the oxidation 
current increased at a slower rate above 10 mM and eventually leveled off 
beyond 15 mM. This is probably due to the saturation of active sites of GOx in 
the membrane since a finite amount of GOx is loaded and any furtherincrease 
in glucose concentration would not give any appreciable increase in the 
oxidation current. Nevertheless, given that a typical healthy blood glucose 
concentration would be between 4.4 and 6.6 mM, this linear dynamic range of 
the biosensor was more than sufficient to quantify at both the higher and lower 
ends of the healthy blood glucose concentration levels. The detection limit, 
estimated as three times of the standard derivation of the background, was 
found to be 0.29 mM. The apparent Michaelis–Menten constant Km, 
frequently used to evaluate the biological activity of immobilized enzyme, 
could be calculated according to the Lineweaver–Burk equation 1/i = 
(Km/imax)(1/C) + 1/imax, where i is the current, imax is the maximum current, and 
C is the glucose concentration.
154, 155
 The Lineweaver–Burk plot of 1/i vs.1/C 
is shown in Figure 3.7B. Based on the Lineweaver–Burk plot, the KMapp was 
calculated to be 11.1 mM. Since Km characterizes the enzyme electrode 
instead of the enzyme itself and that this value is close to that reported for the 
free enzyme (12.4 mM),
156
 the calculated apparent Michaelis–Menten constant 






Figure 3.7. (A) Calibration curve of the glucose biosensor. Supporting 
electrolyte: PBS, poised potential: -0.15 V. (B) The Lineweaver–Burk plot of 
the biosensor at -0.15 V. 
 
It is worth mentioning that this newly developed glucose biosensor exhibits 
prominent electrocatalytic performance for glucose sensing in terms of the 
linear range, limit of detection (LOD), and sensitivity compared to those 
previously reported mediators, as listed in Table 3.1. This outstanding 
electrocatalytic performance is largely attributed to the crosslinked membrane 
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which displays an excellent catalytic activity toward the oxidation of glucose 
by shuttling electrons rapidly between GOx and the substrate GCE.  
One of the main challenges in glucose analysis is the elimination of 
interference response generated by some endogenous species such as AA, DA, 
and UA. These potential interferences were studied with respect to their 
normal physiological levels found in human blood. It was found that the 
presence of 0.1 mM AA, 0.5 M DA, and 0.5 mM UA contribute only 1.9, 0.9, 
and 2.0% to the overall oxidation current of 5 mM glucose, respectively; while 
a mixture of 0.1 mM AA, 0.5 M DA, and 0.5 mM UA contributed only 4.9% 
to the total oxidation current of glucose. This extremely low level of 
interference observed is mainly due to the ultralow operating potential of -0.15 































Os-complex 0.00 0-0.7 0.0003 28.24 
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Os(2,2’bpy)2-RP 0.25 0-10.0 - 16.5 
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1,1'-di-methylferrocene 0.205 1.0-30 - 6.63 
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Furthermore, a common drug, AMP, was previously reported to be an 
interferant in glucose measurements.
160
 The psychological level of AMP in 
blood is between 0.066 and 0.2 mM and it is believed that the diffusion of 
AMP across a porous membrane to the electrode surface will produce an 
interfering current
161
 due to the oxidation of the free phenolic hydroxyl group 
present in AMP.
162
 Nevertheless, at the upper limit of 0.2 mM, AMP only 
contributed to 1.8% of the total oxidation current. Such a low level of 
interferences, again, was mainly due to the ultralow operating potential of -
0.15 V.  
As mentioned previously, molecular oxygen present in blood can lead to the 
natural enzymatic oxidation of glucose by taking away electrons from the 
enzyme and resulting in a lower oxidation current observed in the biosensor. 
Nonetheless, oxidation of the reduced GOx by molecular oxygen still occurs 
in the presence of mediator in most cases as oxygen is always freely diffusing 
in blood and test solution. This could pose a limit on the accuracy of the 
biosensor, particularly at low glucose levels. Therefore, in order to achieve a 
highly selective glucose biosensor, there is a need to suppress the oxygen 
interference. It was found that the presence of acrylamide moieties in the Ru-
RP renders the crosslinked membrane highly hydrophilic which improved the 
glucose/oxygen permeability ratio by effectively retarding the diffusion of 
molecular oxygen. Less than 0.5% difference was observed between the 
oxidation current of 5 mM glucose in PBS before and after thorough purging 
with nitrogen gas. Obviously, this negligible effect from molecular oxygen is 
likely attributed to the excellent mediating power of the Ru-RP and the largely 
retarded oxygen diffusion within the sensing membrane. 
 58 
 












Apple 83.4 5.2 85.8 97.2 
Blackcurrant 33.7 12.5 31.0 108.7 
Guava 29.6 7.8 25.9 114.3 
Mango 46.8 7.5 45.8 102.2 
Orange 38.4 10.1 39.6 97.0 
* Reference glucose concentrations were obtained by using a commercial TRUEbalanceTM 
blood glucose monitoring system produced by Nipro Diagnostics, Inc. 
 
In order to verify the reliability of this newly developed glucose biosensor 
for routine analysis, the biosensor was employed to determine the glucose 
concentration in real samples like fruit juices and blood. However, because of 
the tight safety and ethical regulations governing the use of real blood samples, 
a commercially available control solution (synthetic blood from Roche 
Diagnostics) for glucose meters which contains several basic components that 
mimic human blood was employed in this study instead. The results, as listed 
in Tables 3.2 and 3.3, indicate that this newly developed glucose biosensor can 
be utilized for practical sample testing as desirable accuracy, precision, and 
recovery are obtained. 









1 3.51 7.5 3.41 102.9 
2 5.42 5.1 5.69 95.3 
3 7.76 8.5 7.97 97.4 
 
3.4 Conclusion 
In this report, we demonstrated an interference-free glucose biosensor can 
be constructed by a one-step crosslinking of the ruthenium complex-based 
 59 
 
low-potential redox polymer with GOx. As expected, the newly developed 
glucose biosensor exhibited negligible responses toward all commonly 
observed interferants in glucose detection. And a good linear correlation 
between the oxidation current and the glucose concentration up to 10 mM was 
obtained. These attractive characteristics will open new opportunities in the 




Chapter 4. Detection of glucose with a lamellar-




Nanocrystallized gold is one of the most widely studied materials due to 
their unique catalytic properties, efficient electron transfer performance, and 
good biocompatibility.
163-166
 For example, gold-based nonenzymatic glucose 
sensors are of great interest, due to their intimate connection with the 
worldwide public health problem diabetes mellitus and other applications.
167-
170
 Unlike macrocrystallized metal electrodes with unsatisfying sensitivity,
171
 
gold nanograins exhibit great electrochemical activities derived from their 
high density of edge-plane-like defective sites and large specific surface 
areas.
172
 However, these nanocrystallized gold particles are usually randomly 
scattered or aggregated, which makes it difficult to ensure the utmost catalytic 
active surfaces to interact with reactants. Obviously, it is also impossible to 
precisely describe the mass transport behavior that plays an irreplaceable role 
in electrochemical reactions.
173-175
 So manipulating these nanograin building 
blocks into three-dimensional architecture and optimizing the mass transport 




Various efforts, such as electrostatic interactions and asymmetric 
functionalization of nanoparticle surfaces,
178-180
 have been devoted to 
assemble individual particles into controllable architectures with limited 
success. In contrast, biological systems from nature form sophisticated 
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configurations from macro-, micro- to nano-sizes which provide a large 
structural pool for architecture design.
181
 Recent biotemplated and biomimetic 






 or ordered protein 
assemblies
184
 have been utilized to synthesize and assemble metal nanograin 
architectures; however, those biological templates are easily curved or 
agglomerated themselves.
185
 Thus, searching for a biological template which 
is both rigidly constructed and elaborate in micro/nano-scale for nanograin 
assembly is of great significance. By precise morphology control, we can 
investigate to what extent the architecture impacts on electrochemical 
performance and explore what arrangement is effective for sensing 
applications. 
Having been evolving for over 250 million years, the beauty and variety of 
butterfly wings can hardly be matched by any other species in nature. Nearly 
20,000 types of butterflies are identified solely by the patterns or colors of 
their wings, which comprise scales with different complex 
microarchitectures.
181, 186-188
 This provides a great template warehouse for 
nanograin assembly and for the architecture design of efficient 
electrochemical sensors. In this work, we chose the blue scales from Morph 
butterfly wings, whose brilliant color derives from their lamellar-ridge 
architecture, as a template to synthesize lamellar-ridge architectured gold 
(lamellar ridge-Au) using an electroless deposition method.
189
 Its 
unarchitectured counterpart flat gold (flat-Au) was also synthesized as a 
control using the flat wing membrane as template under the conditions. By 
simply modifying as-prepared lamellar ridge-Au on a glassy carbon electrode 
with Nafion, a sensitive nonenzymatic glucose sensor with good selectivity 
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and stability was developed. The lamellar-ridge architecture arrangement 
showed great promise for electrochemical sensing with enhanced sensitivity 
and lower detection limit compared to its unarchitectured counterpart. Finite 
element modeling and simulation were also carried out to analyze the mass 
transport behavior in the lamellar-ridge architecture and to illustrate the 
architecture assisting effect in mass transport. 
 
4.2 Experimental 
4.2.1 Reagents and apparatus  
Tetrachloroaurate hydrate was purchased from Sigma-Aldrich (St. Luis, 
MO, USA). Tartaric acid, sodium borohydride, and other chemicals for gold 
preparation were all obtained from Sinopharm Group Co., Ltd. Nafion 117 
solution, glucose, uric acid, and ascorbic acid were obtained from Sigma-
Aldrich. All other chemicals of certified analytical grade were obtained from 
Sigma-Aldrich and used as received. All aqueous solutions were prepared with 
ultrapure deionized water (18.3 MΩ). 
The morphology of lamellar ridge-Au was examined under low vacuum 
field emission scanning electron microscope (LV FESEM, NOVA NanoSEM 
230) operated at 5 kV. The composition was verified by X-ray diffraction 
(XRD) using an X-ray diffractometer (D8 ADVANCE) with Cu Kα radiation. 
The surface condition was examined by X-ray photoelectron spectroscopy 
(XPS, AXIS UltraDLD) using Al Kα radiation as the X-ray source. Thermal 
gravimetric analysis (TGA) was carried out on a thermo gravimetric analyzer 
(Pyris 1, PerkinElmer) from room temperature to 800 °C with a heating rate of 
10 °C/min to obtain the net content of gold in the as-synthesized samples. 
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All electrochemical experiments were performed with a CHI760D 
electrochemical workstation (CH Instruments, Austin, TX, USA) at room 
temperature (25°C). A conventional three-electrode system, comprising a 
GCE working electrode modified with gold samples, an Ag/AgCl reference 
electrode, and a platinum wire counter electrode, was employed. All potentials 
reported in this work were referred to the Ag/AgCl reference electrode. 
 
4.2.2 Preparation of gold samples 
Blue scales of Morph butterflies were used as templates for the preparation 
of lamellar ridge-Au. The synthetic process is depicted in Figure 4.1. The 
butterfly wing samples were first immersed in 10 vol% nitric acid for 1 h 
followed by washing with deionized water. Then, the samples were aminated 
by socking in ethanolic solution of ethanediamine (25 vol%) for 6 h followed 
by washing with ethanol. After dried in air, the aminated samples were then 
immersed in aqueous solution of HAuCl4 (0.2 wt%) for 3 h to allow gold 
adsorption. After washing with deionized water, the samples were then 
immersed into 0.1 M aqueous solution of NaBH4 for 120 s to reduce the bound 
gold into gold nanoparticles. The surface functionalized templates were 
achieved after washing with deionized water and dried in air. Further gold 
deposition was achieved by immersing the gold nanoparticle functionalized 
templates into electroless plating solution for 15 min in 25 °C. After the 
deposition, the gold-coated scales were removed from the membrane and 
collected for further detemplating process to obtain lamellar ridge-Au. The 
gold-coated membrane was also collected for flat-Au. The as-prepared gold-
coated scales and gold-coated membrane were treated in phosphoric acid at 
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room temperature for 72 h to remove the bio-templates. These samples were 
then further washed with absolute ethanol and collected by centrifugation and 
dried at 60°C for 12 h. 
 
Figure 4.1. Schematic diagram for the fabrication of lamellar ridge-Au and 
the preparation of the corresponding biosensor. 
 
4.2.3 Glucose sensor fabrication 
A GCE (3-mm diameter) was sequentially polished on a microcloth with 
0.3- and 0.05-μm alumina slurry and sonicated in water and ethanol between 
each polishing step. The as-synthesized gold samples were dispersed in 
deionized water by sonication (1 mg/ml), and then a 5-μl drop of the 
suspension was cast on the freshly cleaned electrode. After drying under 
ambient conditions, 4 μl of 0.5 wt% Nafion solution in ethanol/water (1:2, 
volume ratio) was further dropped on the electrode surface forming a thin 
coating on gold samples after solvent evaporation. 
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4.2.4 Cyclic voltammetric and amperometric experiment 
Cyclic voltammetry was conducted in 0.5 M H2SO4 at a scan rate of 50 
mV/s to determine the electrochemical active surface area (EASA) of the 
modified electrodes. The electrocatalytic behavior of the modified electrode 
was investigated by cyclic voltammetry in 0.1 M NaOH containing 5 mM 
glucose at 50 mV/s. Amperometric detection of glucose was conducted at a 
constant potential of 0.21 V (vs. Ag/AgCl). 
 
4.2.5 Finite element simulation 
Finite element modeling and simulation were conducted with Comsol 
Multiphysics 4.2 software from CnTech using a diffusion domain approach.
190
 
Glucose concentration profiles were portrayed to investigate the mass 
transport behavior in the electrode architecture.  
 
4.3 Results and discussion 
4.3.1 Architecture and composition characterization 
As shown in Figure 4.2, the delicate lamellar-ridge architecture of Morph 
butterfly-scale was successfully duplicated by the electroless deposition. After 
removing the template, the final architecture of as-synthesized gold was hollow 
lamellar ridges with a thickness of 27 nm. The ridge height of lamellar ridge-
Au was 1.7 μm and the distance between ridges was 650 nm. Each ridge was 
substructured by 78 lamellae staggeringly-patterned on either side of the ridge 




Figure 4.2. Microarchitectures of original Morph butterfly scale template and 
as-synthesized lamellar ridge-Au. (a, b) FESEM image of the scale template, (c) 
TEM image showing the cross-sectional view of lamellar-ridge architecture of 
the original scale template, and (d, e) FESEM images showing the front and 




According to XRD patterns in Figure 4.3a, both lamellar ridge-Au and flat-
Au exhibited a typical face-centered cubic lattice structure. The grain size, 
calculated by the Williamson-Hall method, was 7.3 nm and 7.5 nm for 
lamellar ridge-Au and flat-Au, respectively. XPS experiments were then 
conducted to characterize their surfaces. The spectra indicated that both 
lamellar ridge-Au and flat-Au exhibit similar surface conditions. As shown in 
Figure 4.3b, the doublet at 83.5 eV and 87.2 eV correspond to Au 4f5/2 and 
4f7/2, respectively.
191
 The 3.7 eV splitting of each doublet, corresponding to 
the spacing between 4f5/2 and 4f7/2 levels, confirmed the presence of gold in 
zero valent oxidation state.
192, 193
 From the TGA results after detemplation, the 
net content of gold was 88% and 87% for lamellar ridge-Au and flat-Au, 
respectively, suggested that both samples contain a small quantity of residual 




Figure 4.3. Composition characterization for lamellar ridge-Au and flat-Au. (a) 
XRD patterns and (b) XPS spectra. 
 
 
Figure 4.4. Thermal gravimetric analysis of lamellar ridge-Au, flat-Au, and 
butterfly wing template. 
 
4.3.2 Electrochemical examination 
The EASA of the as-prepared gold modified electrodes was determined from 
the charge of the reduction of an oxide monolayer in the cathodic sweep of the 
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cyclic voltammograms in 0.5 M H2SO4 (Figure 4.5a), based on a reported 




 The EASA for lamella ridge-Au modified 
electrode was estiminated to be 23.8 m
2
/gAu, which was 4.8 times higher than 
its unarchitectured counterpart (5.0 m
2
/gAu). The electrocatalytic behavior for 
glucose was investigated by cyclic voltammetry in 0.1 M NaOH with 5 mM 
glucose at a scan rate of 50 mV/s (Figure 4.5b). In the positive scan, a current 
bump around -0.35V was observed, which is due to glucose electrosorption 
forming the gluconolactone intermediate.
167, 195
 As the potential was swept 
more positively, AuOH formed on gold surfaces by the partial discharge of 
OH
-
, and consequently catalyzed the oxidation of glucose.
196
 The 
corresponding anodic peak was at 0.21 V for lamellar ridge-Au, which was 30 
mV more negative than that of flat-Au (0.24 V). The peak current density was 
0.87 mA/cm
2
 for lamellar ridge-Au, which was 5.4 times that of flat-Au (0.16 
mA/cm
2
), indicating great elevation for glucose oxidation. The current density 
dropped at higher potentials because of the formation of gold oxides which 
lead to the decrease of AuOH sites and suppressed oxidation current.
167, 196
 In 
the negative scan, the sharp increase of anodic current was due to the 





Figure 4.5. Cyclic voltammograms at 50 mV/s of lamellar ridge-Au and flat-
Au biosensors in (a) 0.5 M H2SO4 and (b) 0.1 M NaOH containing 5 mM 
glucose. 
 
4.3.3 Amperometric detection of glucose 
Figure 4.6a shows the amperometric plot at the lamellar ridge-Au and flat-
Au modified electrodes with successive addition of different quantity of 
glucose in 0.1 M NaOH solution at an applied potential of 0.21 V. It is 
 70 
 
apparent that the response time was within 5 s to reach 95% of the steady-state 
current. The current response exhibited a good linear correlation with glucose 
concentration for both electrodes. As shown in Figure 4.6b, the linear range 
for the lamellar ridge-Au modified electrode was from 2 μM to 23 mM 
(R
2=0.996) with a sensitivity of 29.0 μA/(mM cm2). The detection limit, 
estimated as three times of standard derivation of background levels, was 
found to be 0.87 μM. As a comparison, the linear range for the unarchitectured 
counterpart (flat-Au) was from 20 μM to 23 mM (R2=0.998) with a sensitivity 
of 5.0 μA/(mM cm2) and a detection limit of 3.26 μM. Considering the same 
composition, grain size, and surface conditions for both lamellar ridge-Au and 
flat-Au, it is apparent that the 5.8 times increase of sensitivity and 3.7 times 
decrease of detection limit should solely originate from the lamellar-ridge 
architecture arrangement. It is also worth noting that architecture effect was 
more impressive at the lower concentrations of linear range, where mass 
transport efficiency is pivotal for the performance of the modified electrode,
197
 
whereas the saturation of active sites play an important role at higher 




Figure 4.6. (a) Amperometric responses and (b) the corresponding calibration 
curves for lamellar ridge-Au and flat-Au biosensors to the successive addition 
of glucose from 2 μM to 23 mM. Poised potential: 0.21 V. 
  
Moreover, the lamellar ridge-Au modified electrode also showed good 
selectivity for glucose detection. As shown in Figure 4.7, the addition of 0.1 
mM UA and 0.1 mM AA at normal physiological level contributed only 2.3% 
to the overall current of 5 mM glucose. The reason is two-fold. First, the low 





the negatively charged Nafion coating effectively blocks the access of UA and 




Figure 4.7. Amperometric response to the successive addition of 0.02 mM 
uric acid and 0.1 mM ascorbic acid interfering compounds, as well as 2 mM 
glucose, for lamellar ridge-Au biosensor. 
 
In order to verify the reliability for routine analysis, a commercial synthetic 
blood from Roche Diagnostics for glucose meters was employed in this study. 
The synthetic blood was diluted 20 times by 0.1 M NaOH before testing. As 
listed in Table 4.1, desirable accuracy, precision, and recovery were obtained. 
 









1 16.83 7.0 17.01 98.6 
2 10.43 4.4 10.24 101.9 




4.3.4 Mass transport analysis 
As discussed above, the 5.8 times increase of sensitivity was more 
significant than the 4.8 times increase of EASA for the lamellar ridge-Au 
modified electrode compared to its flat-Au counterpart, which indicates that 
the enhanced sensitivity should not be solely attributed to the increased EASA. 
As mentioned above, the architecture effect was more impressive at lower 
concentrations, thus suggesting notable influence from mass transport 
assisting effect.
197
 Here, a lamellar-ridge architectured model was built for 
finite element simulation using a diffusion domain approach with a one-ridge 
period as a domain unit.
190
 Glucose concentration profiles were portrayed to 
investigate the mass transport behavior in the electrode architecture. As shown 
in Figure 4.8, compared to the simple one-direction planar diffusion of the 
unarchitectured model, the lamellar-ridge arrangement showed a more 
efficient diffusion behavior, characterized by a zigzag route which is a brilliant 
unimpeded approach to access the catalytic surface efficiently.
175 
Moreover, 
the trapping and depleting of electrolyte between adjacent lamellae also 
greatly promoted diffusion efficiency via thin layer effect, which is of great 
importance in promoting electrochemical reaction.
201, 202
 In fact, thin layer 
diffusion is most frequently discussed in carbon nanotube (CNT) modified 
electrodes. However, electron transfer promotion by CNT is also essential in 
those systems. On the contrary, by constructing the elaborate lamellar-ridge 
architecture and flat two-dimensional structure, this work gives a clear answer 
to the architecture (diffusion) contribution. Furthermore, the negative shift in 
anodic peak for the lamellar ridge-Au modified electrode in Figure 4.5b also 





 small volume of glucose trapped between the 
adjacent lamellae became significantly depleted on the voltammetric timescale 




Figure 4.8. Reactant concentration profiles at t = 100 s in the simulation 
process for lamellar ridge-Au and flat-Au models. 
 
This methodology can be extended to other butterfly-scale architectures or 
even to other natural configurations for more comprehensive investigation of 
different architecture effect, which may provide an efficient approach for 
designing and selecting effective architectures for electrochemical sensors. For 
example, gold samples with inverse-V ridge architecture and ridge/nano-hole 
architecture have been synthesized in our laboratory. This strategy may also be 
extended to other catalytic materials such as platinum, carbon, ceramic oxides, 
and so forth to obtain more efficient electrochemical reactions. 
 
4.4 Conclusion 
In summary, we synthesized gold samples with lamellar-ridge architecture 
templated by blue scales from Morph butterfly wings using an electroless 
deposition method. Benefiting from the elaborate structural arrangement, the 
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lamellar ridge- Au modified electrode exhibited prominent performance for 
glucose sensing in terms of linear range, sensitivity, and detection limit. 
Compared to its unarchitectured counterpart, the electrochemical active 
surface area and the sensitivity for the detection of glucose were dramatically 
increased by 4.8 and 5.8 times, respectively, The lamellar-ridge architecture 
also lowered the detection limit by 3.7 times to 0.87 μM. Besides increased 
electrochemical active surface area, this significant promoting behavior is also 
attributed to the unique zigzag mass transport property and efficient thin layer 
diffusion effect in the lamellar-ridge architecture. This work demonstrated the 
architecture effect on electrochemical detection of glucose, and presented an 
exemplary strategy of using the vast configuration pool from nature to 




Chapter 5. A highly sensitive electrochemical 
methyltransferase activity biosensor 
 
5.1 Introduction 
In this work, a simple and highly sensitive electrochemical biosensor for 
DNA MTase activity measurement was described. DNA cytosine MTase and 
methylation sensitive restriction endonuclease HpaII (recognizes the duplex 
symmetrical sequence 5’-C/CGG-3’) were selected in the biosensor. In 
addition, a synthetic threading intercalator, N,N’-bis(3-propylimidazole)-





was employed for signal amplification. 
PIND-Os strongly and selectively binds to double-stranded DNA and 
catalyzes the oxidation of ascorbic acid at a relatively low potential of 0.22 V 




5.2.1 Reagents and apparatus 
M.SssI CpG methyltransferase (M.SssI MTase) supplied with 10 x 
NEBuffer 2, restriction endonuclease HpaII supplied with 10 x CutSmart 
buffer, HaeIII methyltransferase (HaeIII MTase), AluI methyltransferase (AluI 
MTase) and S-adenosyl-L-methionine were purchased from New England 
Biolabs (Ipswich, MA). 5-azacytidine (5-Aza), 5-aza-2’-deoxycytidine (5-
Aza-dC), and 6-mercapto-1-hexanol (MCH) were from Sigma-Aldrich (St. 
 77 
 
Louis, MO, USA). Tris(hydroxymethyl)aminomethane (Tris), tris(2-
carboxyethyl)phosphine hydrochloride (TCEP) were obtained from Alfa Aesar 
(Lancashire, England). PIND-Os (Scheme 5.1) was synthesized according to a 
published procedure.
205 
Reverse-phase high performance liquid 
chromatography-mass spectrometric test showed that the desired compound 
has been successfully synthesized and its purity was 97%, as indicated by a 
single elution peak and a molecular weight of 1560. Also, various 
spectroscopic tests have confirmed its purity and intercalating properties. All 
other chemicals of certified analytical grade were used without further 
purification. All solutions were prepared with ultrapure water (18.3 MΩ). 
Oligonucleotides used in this work were custom-made by 1
st
 Base Pte Ltd. 
(Singapore). The sequences of the oligonucleotides were as following: 
oligonucleotide 1 (oligo 1): 5’-HS-(CH2)6-AAT CTC AGT GAT TCA TCC 
GGA TAC AAG TAC TCT ATT GAC T-3’ and its partially complementary 
oligonucleotide 2 (oligo 2): 5’-AGT CAA TAG AGT ACT TGT ATC CGG 
ATG AAT CA-3’. The two oligonucleotides were dissolved in TE buffer (10 
mM Tris, 1 mM EDTA, pH 8.0) to the desired concentrations and stored at -20 
ºC. 
 




     Electrochemical experiments including differential pulse voltammetry 
(DPV) and cyclic voltammetry (CV) were performed with a CHI 650D 
electrochemical workstation (CH Instruments, Austin, TX, USA). A 
conventional three-electrode system comprising of a gold working electrode, 
an Ag/AgCl reference electrode, and a platinum wire counter electrode, was 
employed in all electrochemical experiments. All potentials reported in this 
work were referred to the Ag/AgCl reference electrode. Electrochemical 
impedance spectroscopic experiments were conducted with an IM6 
electrochemical workstation (Zahner Elektrik, Germany). 
 
5.2.2 M.SssI MTase catalyzed DNA methylation event confirmation by gel 
electrophoresis 
An oligonucleotide (oligo 3: 5’-AGT CAA TAG AGT ACT TGT ATC 
CGG ATG AAT CAC TGA GAT T-3’) which is fully complementary with 
the thiolated oligo 1 was firstly hybridized with oligo 1 to form the ds-DNA. 
Then, a reaction mixture consisted of 4.0 μM ds-DNA, 160 μM SAM, 8 U 
CpG MTase (M.SssI) in 20 μL 1 x NEBuffer 2 was incubated at 37 ºC for 3 h 
to form the methylated DNA. After that 5 μL of methylated DNA sample was 
mixed with 20 μL 1 x CutSmart buffer that containing 5 U HpaII 
endonuclease, and then incubated at 37 ºC for another 3 h. The ds-DNA that 
only treated with HpaII was prepared by the incubation of a reaction mixture 
that consisting of 1.0 μM ds-DNA and 5 U HpaII endonuclease in 1 x 
CutSmart buffer. Subsequently, the samples were applied to a polyacrylamide 
gel (15%) to evaluate the efficiency of enzyme in 1 x TBE buffer at a constant 
voltage (150 V) for 2 h. The gel was silver-stained. 
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5.2.3 Double-stranded DNA and electrode preparation 
Double-stranded DNA was prepared as follows: The mixture of the two 
oligonucleotides (1.0 M each) and 1.0 mM TCEP was prepared in a 
hybridization buffer (10 mM Tris, 1.0 mM EDTA, 1.0 M NaCl, pH 7.4). The 
solution was then heated to 90 ºC and slowly cooled down to room 
temperature. The prepared ds-DNA stock solution (1.0 M) was kept at 4 ºC 
when not in use. 
     The gold electrode was pretreated according to a reported procedure.
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Briefly, the gold electrode was carefully polished on a microcloth with 0.3 and 
0.05 m alumina slurry sequentially, and followed by a period of 5 min 
sonication in ultrapure water. Then, electrochemical cleaning was performed 
in 0.2 M H2SO4 by applying an anodic potential of 2.0 V for 5 s, and thereafter 
a cathodic potential of -0.35 V for 10 s. Next, repetitive CV scans were 
conducted within a potential window between -0.3 and 1.55 V at a scan rate of 
4 V/s (20 cycles) and 0.1 V/s (4 cycles) in 0.2 M H2SO4, respectively. Finally, 
the electrode was rinsed with copious amount ultrapure water and dried in a 
N2 stream. 
     The immobilization of the ds-DNA to the gold electrode was performed by 
applying 2.5 L of 1.0 M ds-DNA on a freshly cleaned gold electrode 
surface and incubated for 4 h at 37 ºC. The electrode was then washed with 
wash buffer (10 mM Tris, pH 7.4) and ultrapure water sequentially to remove 
the non-specifically adsorbed ds-DNA. Subsequently, the electrode was 
treated with 1.0 mM MCH for 1 h to block the defective sites on the electrode 
and to obtain a well-aligned ds-DNA monolayer. The modification process 
was monitored by both DPV and EIS after each step. DPV was performed in 
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and within a 
potential window range of -0.2 to 0.6 V. EIS experiments were conducted in 
the same solution in the frequency range of  10 mHz to 100 kHz at the 







5.2.4 MTase activity detection 
The ds-DNA coated electrode was first incubated with 2.5 L 1 x NEBuffer 
2 containing a specific concentration of M.SssI MTase, and 160 M SAM at 
37 ºC for 2 h to achieve the methylation at the CpG dinucleotide sites of the 
immobilized ds-DNA. After washing with NEBuffer 2 and drying, the 
electrode was then incubated with 2.5 L 1 x CutSmart buffer containing 50 
U/mL HpaII restriction endonuclease at 37 ºC for 2 h to allow the cleavage 
reaction to take place. After another round of washing with CutSmart buffer 
and drying, the electrode was incubated in 100 g/mL PIND-Os aqueous 
solution for 10 min. Finally, after a thorough rinsing with PBS the AA 
electrooxidation current on the electrode was measured by cyclic voltammetry 
in PBS (20 mM phosphate, 0.15 M NaCl, pH 7.4) containing 5 mM AA. 
  
5.2.5 Selectivity and inhibition investigation of the M.SssI MTase 
biosensor  
To investigate the selectivity of the proposed M.SssI MTase biosensor, two 
other cytosine MTases, namely HaeIII MTase and AluI MTase, were selected 
as the potential interfering enzymes. The selectivity experiments were 
conducted with 100 U/mL MTase in the same way as the M.SssI activity 
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detection procedure, except for that M.SssI MTase was replaced by 
HaeIII/AluI MTase in the methylation step.  
To further study the inhibitor screening ability of the proposed biosensor, 
the inhibition effect of 5-Aza and 5-Aza-dC on M.SssI MTase activity was 
carried out by incubating the ds-DNA coated electrode in 1 x NEBuffer 2 
consisting of 120 U/mL M.SssI and 160 M SAM with various concentrations 
of the inhibitors. After the HpaII digestion and PIND-Os intercalation steps as 
described above, the electrocatalytic oxidation current of AA was recorded on 
the inhibitor treated electrode. The relative activity of M.SssI MTase was 
estimated using the following equation: 
Relative activity (%) =  
𝐼2 − 𝐼0
𝐼1 − 𝐼0
 × 100 % 
where I0 is the catalytic current of 0 U/mL M.SssI MTase, I1 is the catalytic 
current of 120 U/mL M.SssI MTase and I2 is the catalytic current after the 
inhibitor treatment. 
 
5.3 Results and discussion 
5.3.1 MTase activity biosensor principle 
As schematically depicted in Figure 5.1, thiol-modified ds-DNA 
containing the specific M.SssI MTase and HpaII recognition sequence (5’-
CCGG-3’) is firstly immobilized on a gold electrode. After the methylation 
and digestion steps that catalyzed by M.SssI MTase and HpaII respectively, 
PIND-Os is inserted into the remaining ds-DNA. Finally, the electrode is 
brought into a phosphate buffer solution that contains ascorbic acid, and the 
electrocatalytic oxidation current of AA is recorded. According to the 
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procedure, HpaII endonuclease catalyzed cleavage of the immobilized ds-
DNA will be blocked once the CpG dinucleotide site in the 5’-CCGG-3’ 
sequence is methylated, the amount of the remaining ds-DNA after the HpaII 
cleavage is in principle proportional to the activity of M.SssI MTase. Thus, the 
catalytic oxidation current of AA directly reflects the methylation event and 
M.SssI MTase activity. It is worth to note that the oligonucleotides used in this 
work are designed in a way to minimize the background signal as much as 
possible. Oligo 2 is partially complementary to oligo 1, a relatively short 
segment of ds-DNA (9 base pairs) remains at the electrode after HpaII 
cleavage. Considering the low melting temperature (~24 ºC) of this short ds-
DNA strand, it is expected to readily dehybridize under the restriction 
endonuclease incubation conditions, thus achieving a relatively low 
background signal. On the other hand, as little as a single layer of PIND-Os on 
the electrode surface is needed to generate maximal signal in the 
electrocatalytic oxidation of AA. As for the length of the ds-DNA, it should be 
long enough to hold up at least one monolayer equivalent of PIND-Os, but not 
too long to impede the ds-DNA immobilization efficiency. It was found that 




Figure 5.1. Schematic illustration of the M.SssI MTase activity biosensor. 
 
Notably, the DNA methylation event that catalyzed by M.SssI MTase was 
successfully confirmed by gel electrophoresis (Figure 5.2). Meanwhile, the 
two enzymes employed in this work were also confirmed to be active. Thus, 
the obtained evidence by gel electrophoresis makes the proposed 
electrochemical method promising. 
 
 
Figure 5.2. Gel image of (1) ds-DNA, (2) ds-DNA treated with M.SssI MTase, 




5.3.2 Electrochemical characterization of modified electrode and 
feasibility study 
To confirm that the proposed strategy (as illustrated in Figure 5.1) can be 
successfully employed for the M.SssI MTase activity biosensor, DPV 
measurements were performed with the electrode at different stages of the 
modification procedure. As shown in Figure 5.3A, the bare gold electrode 
(trace 1) exhibited a high DPV signal due to free electron transfer of the 
Fe(CN)6
3-/4- 
redox probes at the bare gold electrode. However, when the ds-
DNA was self-assembled on the gold electrode through Au-S covalent bonds 
and followed by the MCH blocking, the ds-DNA/MCH modified gold 
electrode (trace 2) showed a sharp decrease in the DPV current of the 
Fe(CN)6
3-/4- 
redox probes. The decrease in the DPV current is caused by two 
factors–one being the electron transfer impeding power of the ds-DNA and 
MCH mixed monolayer and the other being the electrostatic repulsion between 
the negatively charged phosphate backbone of the ds-DNA and the anionic 
Fe(CN)6
3-/4- 
ions. Thereafter, when the electrode was incubated with 10 U/mL 
M.SssI MTase and 50 U/mL HpaII subsequently, as illustrated in trace 3, the 
DPV current of thus treated electrode increased slightly. This is due evidently 
to the cleavage of the unmethylated ds-DNA by the restriction endonuclease 
HpaII. A control experiment was also conducted with a blank buffer, i.e. the 
methylation process was performed in 1 x NEBuffer 2 that only contained 160 
M SAM. As compared to the M.SssI MTase treated electrode, more ds-DNA 
was removed from the electrode surface after HpaII digestion since no 
methylation is expected in the absence of M.SssI MTase. An even higher DPV 





Figure 5.3. (A) DPV and (B) EIS of (1) a bare gold electrode, (2) ds-
DNA/MCH, (3) ds-DNA/MCH electrode treated by M.SssI MTase/HpaII, and 
(4) ds-DNA/MCH electrode treated by HpaII in 0.10 M Na2SO4 containing 5.0 
mM Fe(CN)6
3-/4-
 (1:1 ratio). 
 
 
     As an effective technique to characterize the electrode/electrolyte interface 
properties and monitor the electron exchange process at the interface,
207
 EIS 
was chosen to further investigate the ds-DNA coated electrode at different 
stage of the biosensor. EIS measurements were performed at the gold 
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electrode during the modification procedure and after the incubations. The 
obtained EIS results coincided well with the DPV results, except for the fact 
that the charge transfer resistance (Rct) is straightforwardly reflected by the 
impedance spectra. As seen in Figure. 5.3B, the bare Au electrode (curve 1) 
shows an almost straight line, implying that there is practically little electron 
transfer resistance. The EIS spectrum of the ds-DNA-MCH mixed monolayer 
coated electrode displayed a semicircle in the high frequency region, and the 
diameter of the semicircle represents the Rct. Moreover, it was found that the 
Rct of the ds-DNA/MCH-modified electrode (curve 2) is larger than that of the 
M.SssI MTase/HpaII treated electrode (curve 3) and the Rct of the M.SssI 
MTase/HpaII treated electrode is larger than that the HpaII treated electrode 
(curve 4). The systematic decrease in Rct agreed well with the DPV results. 
Therefore, based on the above results, it was confirmed that the procedure for 
the preparation of the ds-DNA-MCH coated gold electrode is appropriate and 
the ds-DNA at the electrode surface is fully functional with respect to M.SssI 
MTase and HpaII. 
Furthermore, cyclic voltammogram (CV) characterization of the modified 
electrodes was conducted by using the electrodes that treated with the same 
procedures as the electrodes employed in DPV and EIS characterization 
experiments. The CV results agree with that of DPV and EIS, as can be seen 




Figure 5.4. Voltammetric characterization of (1) a bare gold electrode, (2) ds-
DNA/MCH, (3) ds-DNA/MCH electrode treated by M.SssI MTase/HpaII, and 





 (1:1 ratio). Potential scan rate: 100 mV/s. 
 
 
Figure 5.5. Voltammograms of (1) a PIND-Os treated ds-DNA/MCH electrode 
in blank PBS; (2) a ds-DNA/MCH electrode, (3) a HpaII treated ds-
DNA/MCH/electrode, and (4) a M.SssI MTase/HpaII treated ds-DNA/MCH/ 
electrode in PBS containing 5 mM AA. 2 h methylation, 2 h incubation in 50 
U/mL of HpaII, and 10 min incubation in 100 g/mL PIND-Os. Potential scan 
rate: 100 mV/s. 
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     In order to verify the intercalating property of PIND-Os, the ds-DNA/MCH 
coated electrode was incubated in 100 g/mL PIND-Os for 10 min, and then 
the electrode was characterized by CV in blank PBS after a thorough washing. 
As shown in trace 1 in Figure 5.5, a pair of reversible voltammetric peaks 
centered at 0.18 V that are assigned to the redox reactions of PIND-Os were 
observed,
205 
thus suggesting the successful attachment of PIND-Os to the ds-
DNA via threading intercalation. The charge under either the oxidation or the 
reduction current peak is directly associated with the amount of the 
intercalated PIND-Os and hence the amount of the ds-DNA on the electrode 
surface. Furthermore, as expected, the voltammogram of the ds-DNA coated 
electrode without PIND-Os treatment showed little current for the oxidation of 
AA at potentials <0.40 V due to the slow heterogeneous electron-transfer rate 
of AA caused by a high oxidation overpotential at gold electrode (trace 2). It is 
well-documented that direct electrooxidation of AA is totally irreversible and 
suffers from very high overpotentials. Reported values for its oxidation range 
from 0.3 to 0.6 V.
148, 149
 The presence of the ds-DNA/MCH mixed monolayer 
on the electrode further impedes the electron transfer. Also, the voltammetric 
behavior of the electrode in PBS containing 5 mM AA after the PIND-Os 
incubation was investigated. As seen in trace 3 and trace 4 of Figure 5.5, after 
the PIND-Os intercalation step, the anodic peak potential (Ep) for the 
oxidation of AA is significantly shifted to ~0.22 V at both the ds-DNA/MCH 
electrodes treated by HpaII/PIND-Os and M.SssI MTase/HpaII/PIND-Os, a 
direct consequence of the improvement in the reversibility of the electron 
transfer from AA to the gold electrode. In addition, the anodic peak current (Ip) 
is also improved as much as ~3 folds, which is attributed to the excellent 
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electrocatalytic effect of PIND-Os. Remarkably, the Ip for the electrode treated 
with 100 U/mL M.SssI MTase is ~5 A higher than that without the M.SssI 
MTase treatment. As a result, the M.SssI MTase activity can be quantified in 
principle through monitoring the electrocatalytic oxidation current of AA. 
           
5.3.3 M.SssI MTase activity determination  
To evaluate the analytical performance of the proposed M.SssI MTase 
activity biosensor, the ds-DNA/MCH modified electrodes were treated with 
various concentrations of M.SssI MTase (0-120 U/mL) in the methylation step 
and followed by the incubation with 50 U/mL HpaII and 100 g/mL PIND-Os 
successively. Under selected experimental conditions, the correlation between 
the electrocatalytic oxidation current of AA and the activity of M.SssI MTase 
was investigated. It was found that the catalytic oxidation current of AA 
increases with the increase of the activity of M.SssI MTase. This is because 
the higher the M.SssI MTase activity, the higher the methylation level, the 
more ds-DNA remaining on the electrode surface, and thus, the higher the 
concentration of PIND-Os bound to the ds-DNA, which in turn, generates a 
higher catalytic oxidation current of AA. As illustrated in Figure 5.6, the 
electrocatalytic oxidation current of AA exhibited a linear correlation to the 
activity of M.SssI MTase ranged from 0 to 120 U/mL with a current 
sensitivity of 0.046 A mL U-1and an R2 of 0.991. Owing mainly to the 
excellent electrocatalytic property of PIND-Os toward AA oxidation, the 
sensitivity of this method is much higher than previously reported graphene 
oxide nanomaterial-based
111
 and enzymatic HRP-based
115





Figure 5.6. The calibration curve of the M.SssI MTase activity biosensor.  
 
5.3.4 Selectivity of the M.SssI MTase activity biosensor  
HaeIII MTase modifies the internal cytosine residues in the sequence of 
symmetric tetranucleotide 5’-GGCC-3’, and AluI MTase methylates the 
cytosine residues in the double-stranded symmetric 5’-AGCT-3’ sequence. As 
shown in Figure 5.7, the catalytic current of M.SssI MTase was about 39 and 
17 times higher than that of HaeIII and AluI, respectively. This is evidently 
due to the fact that the CpG dinucleotide site in the HpaII endonuclease 
recognition sequence (5’-CCGG-3’) cannot be methylated by the HaeIII and 
AluI cytosine MTase. Consequently, the ds-DNA strands were cleaved off 
from the electrode surface in the HpaII incubation step. Therefore, the 
proposed biosensor exhibited good selectivity toward M.SSSI over HaeIII 




Figure 5.7. Responses of ds-DNA/MCH electrodes when treated with 100 
U/mL HaeIII MTase, AluI MTase and M.SssI, respectively. 
 
5.3.5 Influence of inhibitors on M.SssI MTase activity  
Many studies have revealed that DNA MTase inhibitors can reversibly 
alter the methylation level in DNA methylation-associated tumor and cancer, 
and hence the development of MTase inhibitors has provided an effective tool 
for epigenetic cancer therapy.
208
 To investigate the inhibitor screening ability 
of the proposed biosensor, 5-Aza and 5-Aza-dC were selected as the model 
inhibitors. Both of the compounds are nucleoside analogues and proven to be 
able to be incorporated into DNA to trap and inactivate DNA MTase.
209
 The 
inhibition effects of 5-Aza and 5-Aza-dC on M.SssI MTase are illustrated in 
Figure 5.8A and B, respectively. As shown in Figure 5.8, in both cases, the 
relative activity of M.SssI MTase decreased monotonically with the increasing 
concentrations of the inhibitors in a dose-dependent manner. It is worth to note 
that, 5-Aza-dC exhibited a higher inhibition efficiency than that of 5-Aza. This 
is in accordance with the fact that 5-Aza-dC does not need to be modified to a 
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deoxy form and can be more directly incorporated into DNA.
209
 The half 
maximal inhibitory concentration (IC50) represents the concentration of a drug 
that is required for 50% decrease in enzyme activity in vitro. The IC50 values 
for 5-Aza and 5-Aza-dC were obtained from the plots of the relative activity 
of M.SssI MTase versus the concentrations of inhibitors, and they were found 
to be ~4.2 and 3.2 M, respectively. These results demonstrated that the 
proposed M.SssI MTase activity biosensor can be successfully applied in 
MTase inhibitor screening and is a potentially useful tool for anticancer drug 
discovery. 
 





     In summary, a simple and highly sensitive electrochemical method has 
been developed for M.SssI MTase activity biosensor. High sensitivity was 
achieved by employing an excellent electrocatalytic PIND-Os threading 
intercalator toward the oxidation of AA as the signal amplifier. Inhibitor 
screening capability of the proposed biosensor has also been demonstrated. 
Since DNA methylation and DNA MTase play important roles in many 
biological processes and have become important biomarkers in tumor and 
cancer. Hence, the developed M.SssI MTase activity biosensor is an attractive 
candidate for the development of a simple and highly sensitive M.SssI MTase 




Chapter 6. MoS2 nanosheets as an effective 




Benefited from the rapid development of nanoscience, lots of nanomaterials 
have been employed in the DNA MTase biosensors to act as either signal 
producer or signal amplifier. For example, Ouyang and coworkers have 
reported a low-background Dam MTase activity sensing platform using 
carboxylated carbon nanoparticle as fluorescent quencher coupled with a DNA 
intercalator dye.
138
 Liu et al. have also established a sensitive Dam MTase 
activity biosensor based on the methylation/cleavage reaction induced 
aggregation of duplex DNA substrate modified gold nanoparticles.
122
 In 
addition, based on the signal transduction and amplification of single wall 
carbon nanotubes, a label-free electrochemical approach for the detection of 
MTase activity has been confirmed by Wang and collaborators.
210
 
As a conceptually new class of nanomaterials, two-dimensional (2D) 
inorganic graphene analogues (IGAs) have been considered to be an emerging 
area in nanoscience.
211, 212
 Due to the unique electronic properties that driven 
from their ultrathin structure, IGAs such as layered transition metal 
dichalcogenides (TMDCs, e.g., MoS2 and WS2) and boron nitride, have drawn 
intensive attentions in the past few years. These materials have shown various 
potential applications in catalysis, energy storage, and sensing.
213-215
 Up to 
now, the biosensing applications of IGAs are relatively rare and yet to be fully 
discovered. In 2013, Zhang’s group reported the usage of single-layer MoS2 
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for homogenously detection of DNA and adenosine for the first time.
216
 Much 
more recently, based on the fact that 2D TMDCs preferentially absorb single-
stranded oligonucleotide toward double-stranded one, similar approaches were 
developed for DNA and MicroRNA sensing by using WS2 nanosheets.
217, 218
 
Moreover, some other biological sensing systems involving layered MoS2 
nanomaterial have been investigated for the detection of glucose, cancer 
biomarkers, and hydrogen peroxide.
219-221
 
Motivated by the above mentioned biological sensing works based on the 
newly emerging 2D layered IGAs, we explored the application of MoS2 
nanosheets in the MTase activity biosensor. In this work, a signal-on 
fluorescent Dam MTase activity biosensor employing MoS2 nanosheets as 
fluorescence quencher was successfully demonstrated. Its simplicity, rapidity, 
low cost in conjunction with high sensitivity and selectivity makes it attractive 
as a candidate for MTase activity analysis. 
 
6.2 Experimental 
6.2.1 Materials and apparatus 
Molybdenum (IV) sulphide and 5-fluorouracil were purchased from Sigma-
Aldrich (St. Louis, MO, USA). Tris(hydroxymethyl)aminoethane (Tris) was 
obtained from Alfa Aesar (Lancashire, England). Dam MTase, AluI MTase, 
M.SssI MTase, DpnI endonuclease, S-adenosyl-L-methionine were purchased 
from New England Biolabs (Ipswich, MA). The Dam methylation and DpnI 
cleavage reactions were performed in a reaction buffer (R buffer: 20 mM Tris-
HAc, 50 mM KAc, 10 mM Mg(Ac)2, 100 g/mL BSA, pH 7.9). 
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Oligonucleotides used in this work were custom-made by 1st Base Pte Ltd. 
(Singapore). The sequences of the oligonucleotides were as following: 
oligonucleotide 1 (oligo 1): 5’-CCT GGA GTT GAT CAT ATC TGG ACC 
TAT AGT TCA CTT-3’ and the FAM dye labeled partially complementary 
oligonucleotide 2 (oligo 2): 5’-FAM-TAT GAT CAA CTC CAG G-3’. The 
two oligonucleotides were dissolved in TE buffer (10 mM Tris, 1 mM EDTA, 
pH 8.0) to the desired concentrations and stored at -20 ºC. All other chemicals 
of certified analytical grade were used without further purification. All 
aqueous solutions were prepared with ultrapure water (18.3 MΩ). 
Atomic force microscope (AFM) image of layered MoS2 was acquired with 
a tapping mode on Veeco Digital instruments Dimension 3000 SPM. The 
fluorescence lifetime decay of FAM-labeled substrate DNA in the absence and 
in the presence of MoS2 nanosheets was measured by using a time-correlated 
single photon counting (TCSPC) technique. The frequency-doubled output 
(420 nm) of an Avesta TiF-100M femtosecond Ti:sapphire oscillator was used 
as the excitation source. Fluorescence at 520 nm was collected by an optical 
fiber that is directed to an avalanche photodiode. The signals were processed 
by a TCSPC module (PicoQuant, PicoHarp 300) with temporal resolution of 
∼150 ps. UV-vis absorption spectrum was recorded on an Agilent Cary 60 
UV-vis spectrophotometer. Fluorescence was recorded on an Agilent Cary 
Eclipse fluorescence spectrophotometer. 
 
6.2.2 Preparation of MoS2 nanosheets 
The MoS2 nanosheets were prepared according to a reported mixed-solvent 
exfoliation procedure with some modifications.
222
 Briefly, 150 mg MoS2 
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powder was added to a 100 mL flask, 50 mL ethanol/water (45%, v/v) was 
added as dispersion solvent. The mixture was sonicated for 8 h, and then the 
dispersion was centrifuged at 5000 rpm for 30 min to remove aggregates. The 
supernatant was collected and the concentration of the MoS2 nanosheets 
dispersion was measured by UV-vis spectrophotometer. 
 
6.2.3 Feasibility study 
Double-stranded DNA substrate was prepared by mixing equal moles of 
oligo 1 and oligo 2 in a hybridization buffer (10 mM Tris-HCl, 100 mM NaCl, 
pH 7.4), the mixture was heated to 90 ºC for 5 min, then slowly cooled down 
to room temperature, and stored at 4 ºC if not in use. To investigate the 
activity of Dam and DpnI in the same R buffer and avoid the change of buffers 
for different enzymatic reactions, different ds-DNA samples were prepared by 
treating 4 M ds-DNA with 16 unit Dam, 20 unit DpnI, and 16 unit Dam + 20 
unit DpnI in R buffer containing 160 M SAM respectively. Both the 
methylation and cleavage reaction were performed at 37 ºC for 2 h. Then, the 
DNA samples were characterized by 15% polyacrylamide gel electrophoresis. 
On the other hand, to evaluate the fluorescence quenching and recovery 
mediated by MoS2 nanosheets, 50 L 100 nM ds-DNA and 50 L 100 nM 
Dam/DpnI pre-treated ds-DNA in R buffer were mixed with 50 L as-
prepared MoS2 nanosheets respectively. The mixtures were allowed to stand 
for 15 min, and then centrifuged at 6000 rpm for 1 min to minimize the 
background signal. Finally, the supernatant was collected by pipette for 




6.2.4 Dam methyltransferase activity detection 
The enzymatic reactions were conducted in a 200 L total reaction volume. 
The typical reaction mixture consisted of 100 nM ds-DNA, 160 M SAM, and 
various concentrations of Dam MTase in R buffer. The mixture was first 
incubated at 37 ºC for 2 h, then 0.5 L of 20000 U/mL DpnI was added and 
further incubated for another 2 h. After reaction, 50 L of the mixture was 
mixed with 50 L as-prepared MoS2 nanosheets for 10 min at room 
temperature, followed by centrifugation at 6000 rpm for 1 min. The 
fluorescence intensity of the supernatant was recorded finally. 
 
6.2.5 Selectivity and inhibition study 
The selectivity of the proposed Dam activity biosensor was evaluated by 
using two other kinds of MTases. The procedure was the same as the above 
described Dam activity detection procedure, except that Dam was replaced by 
AluI and M.SssI respectively. The concentration of MTase was 20 U/mL for 
each. Similarly, the inhibition study was carried out in the same procedure 
with 20 U/mL Dam MTase, and different concentrations of 5-fluorouracil 
were added together with Dam in the methylation process. Control 
experiments were also performed without addition of Dam MTase in both the 
selectivity and inhibition studies. The relative activity of Dam MTase activity 
inhibited was calculated as follows:    
𝑅𝑒𝑙𝑎𝑡𝑖𝑣𝑒 𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦 (%) =  
𝐹2 − 𝐹0
𝐹1 − 𝐹0
 × 100 % 
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where F0 is the fluorescence intensity of 0 U/mL Dam MTase, F1 is the 
fluorescence intensity of 20 U/mL Dam MTase and F2 is the fluorescence 
intensity after the inhibitor treatment. 
 
6.3 Results and discussion 
6.3.1 Characterization of MoS2 nanosheets 
The MoS2 nanosheets was prepared by a simple sonication assisted 
ethanol/water mixed solvent exfoliation method from the bulk MoS2 powder. 
The obtained dark-green suspension (Figure 6.1 inset) was highly stable, and 
showed no precipitation after being stored for several weeks under ambient 
conditions. Figure 6.1 shows the UV-vis spectrum of the suspension which 
agrees well with the reported results.
212, 222
 The two absorption peaks at around 
610 nm and 670 nm, which can be attributed to the characteristic A1 and B1 
direct excitonic transitions of MoS2 with the energy split from valence band 
spin-orbital coupling, indicate the existence of layered MoS2 dispersed in the 
mixed solvent. Assuming that the dispersion obeys Lambert-Beer law, the 
concentration of the dispersion was calculated to be 3.5 g/mL by using the 










Figure 6.1. UV-vis spectrum of as-prepared MoS2 nanosheets. Inset: 
photograph of the MoS2 nanosheet suspension. 
 
 
The morphology and thickness of the MoS2 nanosheets were characterized 
by AFM. As shown in Figure 6.2, the as-prepared MoS2 had an average 
dimension of few tens of nanometers and a height of around 2 nanometers, 
indicating that they are not single layered (thickness 0.65 nm) but stacked few 
layers. 
 




6.3.2 Principle and feasibility of the Dam MTase activity biosensor 
Early studies have reported that aromatic (e.g. pyridine, purine, etc.) and 
conjugated compounds can be physically absorbed on the basal plane of MoS2 
using either theoretical calculation or experimental studies.
223, 224
 Moreover, 
recent studies have revealed that layered 2D TMDCs, like MoS2 and WS2, 
could adsorb oligonucleotides via van der Waals and could effectively quench 
the fluorescence of fluorophores labeled at the end of absorbed single-stranded 
DNA via energy transfer.
216-218
 To adopt MoS2 nanosheets as a fluorescence 
quencher for homogenously detection of Dam MTase activity, Dam 
MTase/DpnI, which specifically methylates/cleaves the adenosine residues in 
the double-strand 5’-GATC-3’ DNA sequence, was chosen as the 
MTase/endonuclease model. The substrate DNA consisted of a single-stranded 
region for MoS2 absorption and a double-stranded region containing the 
Dam/DpnI recognition site, a FAM fluorescent dye was conjugated at the 
inner end of the duplex region. As illustrated in Figure 6.3, substrate DNAs 
were successively treated with Dam and DpnI, methylated DNAs were 
specifically cleaved by the methylation sensitive endonuclease DpnI. After 
cleavage, the remaining fluorophore conjugated 5-bases segment was highly 
expected to be released as result of the extremely low melting temperature of 
the 5-base pair duplex region. Upon the addition of MoS2 nanosheets, 
fluorescence of non-methylated DNA was quenched due to the close contact 
of fluorophore and MoS2 nanosheets. However, the fluorescence of the short 





Figure 6.3. Schematic illustration of proposed fluorescent Dam MTase 
activity biosensor. 
 
To avoid changing buffer for different enzymatic reactions, the activity of 
Dam and DpnI was firstly evaluated in R buffer. DNA substrates were 
successively treated with Dam and DpnI, and solely treated with Dam or DpnI 
for contrast as well. The gel image in Figure 6.4a shows that there are two 
split bands in the Dam + DpnI treated sample (lane 4), the upper band at the 
same position with controls (lane 1, lane 2, and lane 3) was the non-
methylated substrate DNA, and the lower band was the cleaved DNA 
fragments (25 bases ss-DNA and 24 bases ds-DNA). The result indicated the 
successful methylation and cleavage reaction and thus the guaranteed activity 
of the two enzymes in R buffer. The melting temperature of the 5-base pair 
remaining duplex region is calculated to be less than 10 ºC in R buffer, 
therefore the fluorophore labeled 5-bases fragment readily dehybridizes and 
desorbs from the MoS2 nanosheets after the DpnI cleavage. It was found that 
the fluorophore-labeled fragment of having up to 10 bases readily desorbs 
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from MoS2 nanosheets after cleavage. Figure 6.4b shows the fluorescence 
quenching-restoration behavior mediated by MoS2 nanosheets. As can be seen, 
the fluorescence of FAM-labeled substrate was almost fully quenched in the 
presence of MoS2 (trace 1, 2), whereas the fluorescence was turned on when 
the substrate DNA was treated with Dam and DpnI, which resulted from the 
partially released fluorophores.  
 
 
Figure 6.4. (a) Gel image of 4 M substrate DNA. Lane 1: ds-DNA, lane 2: 
Dam treated ds-DNA, lane 3: DpnI treated ds-DNA, and lane 4: Dam + DpnI 
treated ds-DNA. (b) Fluorescence emission spectra of substrate ds-DNA, 
substrate ds-DNA with the MoS2 nanosheets, and Dam/DpnI treated substrate 
ds-DNA with the MoS2 nanosheets. Excitation wavelength: 495 nm. 
 
 
In addition, to further understand the quenching mechanism, the 
fluorescence lifetime of FAM labeled substrate DNA in the absence and in the 
presence of MoS2 was measured (Figure 6.5). In the presence of MoS2 
nanosheets, the fluorophore displayed faster decay than the free FAM-labeled 
substrate DNA, indicating the quenching mechanism is dynamic, thus clearly 
confirming the feasibility of employing MoS2 nanosheets as an effective 




Figure 6.5. Fluorescence lifetime decay of FAM-labeled DNA in the absence 
and in the presence of the MoS2 nanosheets. FAM-labeled ds-DNA: 100 nM, 
MoS2 nanosheets: 0.5 g/mL. 
 
6.3.3 Dam methyltransferase activity detection 
To obtain sufficient quenching efficiency with minimal MoS2 quencher, the 
amount of MoS2 was optimized (Figure 6.6). It was found that the optimal 
concentration of MoS2 in the final reaction system is 1.75 g/mL. It is worth 
to note that in under the experiment conditions, MoS2 nanosheets showed 
superior quenching efficiency when compared with graphene oxide (GO) as 





Figure 6.6. Quenching efficiency of FAM-labeled substrate DNA with the 




Figure 6.7. Fluorescence quenching by the MoS2 nanosheets and GO. 
 
 
Next, the time needed to reach the equilibrium upon the addition of MoS2 
was investigated as well. As shown in Figure 6.8, the quenching process is 
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very fast. The fluorescence intensity decreased sharply in the first 20 s, and 
almost reached the equilibrium within 10 min. Thereafter, the DNA sample 
and MoS2 mixture was allowed to stand for 10 min before fluorescence 
recording. It is worth to mention that centrifugation could effectively reduce 
the background signal. This could be attributed to the possibility that the 
single-stranded region of some FAM-labeled substrate DNA was partially 
absorbed on MoS2, the FAM fluorophore was hang over outside of the MoS2 
nanosheets, the fluorescence of FAM in such case could not be quenched 
effectively due to the long distance between the fluorophore (energy donor) 
and MoS2 (energy acceptor).  However, the partially absorbed substrate DNA 
could be separated from the solution together with MoS2 under the 
centrifugation force, which contributed to the low background signal. 
 
 





Under the optimal experiment conditions, the performance of the developed 
biosensor for quantitative detection of Dam MTase activity was further 
examined. Figure 6.9a displays the fluorescence emission spectra of the 
sensing system treated with different concentrations of Dam MTase, the 
fluorescence intensity increased rapidly as the Dam MTase concentrations 
varied from 0 to 20 U/mL, and gradually levelled off beyond 20 U/mL. The 
corresponding calibration curve was plotted in Figure 5.9b. The linear 
relationship between the fluorescence intensity at 518 nm and the Dam MTase 
concentration was observed from 0.2 to 20 U/mL with satisfactory sensitivity 
and a correlation coefficient (R
2
) of 0.99. The detection limit was estimated to 
be 0.14 U/mL based on three times the standard deviation of the background 
fluorescence signal over the slope of calibration curve. The performance of the 








Figure 6.9. (a) Fluorescence spectra of FAM-labeled substrate DNA that 
treated with different concentrations of Dam MTase: 0 (control), 0.2, 0.5, 1, 2, 
5, 10, 20, 30, 40, 50, and 60 U/mL. Excitation wavelength: 495 nm.  (b) The 
corresponding plot of fluorescence intensity versus the concentration of Dam 
MTase from 0 to 60 U/mL. Inset: linear correlation from 0.2 to 20 U/mL. 
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6.3.4 Selectivity and inhibition study 
The selectivity of the proposed Dam MTase activity biosensor was further 
investigated using AluI MTase and M.SssI MTase as the interference enzymes. 
Both AluI MTase and M.SssI MTase belong to the DNA cytosine 
methyltransferase family. AluI MTase specifically methylates the cytosine 
residue (C
5) of the sequence 5’-AGCT-3’ within the duplex DNA, and M.SssI 
modifies the cytosine residue (C
5
) within the double-stranded dinucleotide 
recognition sequence 5’-CG-3’. As depicted in Figure 6.10, both the 
fluorescence response of AluI MTase and M.SssI MTase were practically the 
same as the control. In contrast, significantly higher fluorescence intensity was 
obtained with Dam MTase, thus readily allowing highly selective detection of 
Dam MTase activity. Therefore, the proposed biosensor exhibits extraordinary 
selectivity and can easily discriminate Dam MTase from other interference 
enzymes owing to the highly specific sequence recognition of Dam MTase 
towards the substrate DNA. 
 
Figure 6.10. Selectivity of proposed Dam MTase activity biosensor toward 




Since Dam MTase is essential for bacterial virulence, Dam inhibitors are 
likely to have broad antimicrobial action, and the investigation of Dam 
inhibition is of great importance for antimicrobial drug development.
225
 5-
fluorouracil, a well-known inhibitor of MTase which has been popularly used 
for cancer therapy for about 40 years,
226, 227
 was selected as the model Dam 
MTase inhibitor in this study. Figure 6.11 shows that the relative activity of 
Dam MTase monotonically decreased with the increasing concentrations of 5-
fluorouracil in a dose-dependent manner. The IC50 (half maximal inhibitory 
concentration) value of 5-fluorouracil was calculated to be 17.7 M. Hence, 
the proposed method is demonstrated to be a potential useful tool for 
antimicrobial drug discovery. 
 
Figure 6.11. Relative activity of Dam MTase inhibited by different 




In summary, a simple homogeneous fluorescent biosensor for the detection 
of Dam MTase activity by employing the MoS2 nanosheets as the energy 
acceptor in fluorescence quenching has been developed. Good sensitivity and 
selectivity were observed. The fluorescence “turn on” strategy greatly 
improved the suitability of the biosensor in MTase activity assessments. The 
simplicity, high sensitivity, and the usage of newly emerging MoS2 nanosheets 
are some of the interesting features for the development of a simple, robust, 
low cost, and highly sensitive MTase activity biosensor for uses in 
decentralized settings. In addition, the successful application of the MoS2 
nanosheets in MTase activity quantification not only made the biological 
applications of the new emerging 2D IGAs a step further, but also provided a 
potentially useful platform for sensitive Dam MTase activity monitoring and 
for MTase inhibitor screening in biomedical research and clinical diagnosis.  
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Chapter 7. DAN methyltransferase activity detection 
using a personal glucose meter 
 
7.1 Introduction 
As reviewed previously, the reported DNA MTase activity monitoring 
methods depend on either radioisotope labeled substrates, demanding 
expensive equipment, or/and trained operators, which limit the MTase activity 
analysis to centralized facilities. Therefore, there is an unmet need for 
developing simple methods to detect MTase activity at point-of-care.   
Due to its miniaturization, low cost, ease of operation, and reliable 
quantitative results, personal glucose meter (PGM) is one of the most 
successful portable devices for point-of-care testing.
29
 The recent integration 
of the PGM into mobile phones can further facilitate its even wider use by the 
public.
228
 However, the PGM can only detect glucose depending on the 
excellent specificity of the GOx or GDH incorporated into the commercially 
available the PGM. The pioneering efforts on expanding the PGM applications 
for non-glucose targets were reported by Lu’s group.229-232 In their studies, an 
invertase,
233
 which catalyzes the hydrolysis of sucrose to glucose and fructose, 
was conjugated with various functional DNAs such as DNAzymes, aptamers 
and aptazymes. Thus, the use of DNA-invertase conjugates linked glucose 
detection to the monitoring of other targets, and the concentration of produced 
glucose was used to quantify the non-glucose targets of interest. Later, 
following the DNA-invertase conjugation strategy, other researchers reported 
the PGM-based sensing platforms for DNA,
234-236
 platelet-derived growth 
factor-BB,
237
 and telomerase activity
238
. Besides, several sandwich-type 
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immunoassays that used invertase produced glucose as a signal producer were 





 and transcription factors.
242
 In addition, the detection of copper (II) 
ions and histidine were realized by combining the PGM with click 
chemistry.
243, 244





 were also utilized to adapt the PGM for 
non-glucose target analysis. Furthermore, glucose was directly encapsulated 
into mesoporous materials, the target induced cargo release of glucose which 
indicates the presence of targets was then detected by the PGM.
247-249  
To the best of our knowledge, no DNA MTase activity biosensors using the 
PGM as signal readout has been reported up to date. In this work, we proposed 
to expand the use of the PGM for MTase activity detection by coupling with 
the methylation sensitive restriction endonuclease. M.SssI and HpaII were 
chosen as MTase and endonuclease model to demonstrate the working 
principle of the proposed biosensor. Streptavidin coated magnetic beads were 
employed to immobilize invertase conjugated MTase substrate DNA and 
facilitate ease separation. After the methylation/cleavage reaction, the 
remaining invertase-DNA conjugates on the magnetic beads catalyzed the 
hydrolysis of sucrose. The final readout from the PGM could quantify the 
activity of MTase. This simple, robust, and sensitive M.SssI MTase activity 




7.2 Experimental  
7.2.1 Reagents and apparatus 
M.SssI CpG MTase (M.SssI MTase) supplied with 10× NEBuffer 2, 
restriction endonuclease HpaII supplied with 10× CutSmart buffer, HaeIII 
MTase, AluI MTase, Dam MTase, and SAM were purchased from New 
England Biolabs (Ipswich, MA). Streptavidin-coated magnetic beads (2.8 µm 
diameter) were purchased from Invitrogen (Oslo, Norway). Grade VII 
invertase from baker’s yeast (S. cerevisiae) and 4-(N-Maleimidomethyl) 
cyclohexane-1-carboxylic acid 3-sulfo-N-hydroxysuccinimide ester sodium 
salt (sulfo-SMCC) were from Sigma-Aldrich (St. Louis, MO, USA). Tris (2-
carboxyethyl) phosphine hydrochloride (TCEP) and sucrose were obtained 
from Alfa Aesar (Lancashire, England). All other chemicals of certified 
analytical grade were used without further purification. All solutions were 
prepared with ultrapure water (18.3 MΩ.cm). Oligonucleotides used in this 
work were custom-made by 1
st
 Base Pte Ltd. (Singapore). The sequences of 
the oligonucleotides were as follows: oligonucleotide 1 (oligo 1), 5’-
/5ThioMC6-D/AAA AAA AAA ATC TTG ACA TAA ATA CCG GAA TCT 
AAC ATT AGT TC-3’ and oligonucleotide 2 (oligo 2), 5’-/5Biosg/AAA AAA 
AAA GAA CTA ATG TTA GAT TCC GGT ATT TAT GTC AAG AT-3’. 
The two oligonucleotides were dissolved in ultrapure water to 1.0 mM and 
stored at −20 °C.  
The glucose meter (TRUEresult
®
) and test strips were from Nipro 
Diagnostics, Inc. The detection range of the glucose meter is 1.1-33.3 mM. 
Amicon 3k and Amicon 100 K centrifuge filters were from ThermoScientific. 
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Gel electrophoresis was performed on a Bio-Rad Mini-Protean electrophoresis 
system. 
 
7.2.2 Preparation and characterization of DNA-invertase conjugates 
The use of sulfo-SMCC as the linker for the conjugation of thiol-modified 
DNA (oligo 1) with invertase was carried out according to a published 
procedure with some minor modifications.
187
 To 40 µL of 1.0 mM oligo 1 in 
ultrapure water, 3 µL of 1.0 M pH 5.5 PBS buffer and 3 µL of 30 mM TCEP 
in ultrapure water were added, and the mixture was kept at room temperature 
for an hour to break the disulfide bonds. The reduced oligo 1 was then washed 
three times with buffer A (0.1 M NaCl, 0.1 M sodium phosphate buffer, pH 
7.3) using Amicon 3K. The mixture containing 400 µL of 20 mg/mL invertase 
in Buffer A and 1 mg of sulfo-SMCC, was placed on the shaker for 1 hour 
after vortexing for 5 minutes. Excess insoluble sulfo-SMCC was removed by 
centrifugation and the solution was mixed with the reduced oligo 1 and kept at 
room temperature for 72 hours. To remove unreacted thiol-DNA, this solution 
was washed three times by Amicon 100 K with Buffer A.  
 
Table 7.1. SDS-PAGE gel preparation. 
Components Resolving gel Stacking gel 
30% acrylamide/bisacrylamide 1.35 mL 350 L 
1.5 M Tris-HCl, pH 8.8 1.25 mL - 
0.5 M Tris-HCl, pH 6.8 - 625 L 
10% SDS 50 L 25 L 
10% ammonium persulfate 30 L 13L 
TEMED 6.5 L 5 L 




The oligo 1-invertase conjugates were characterized by 8% SDS-
polyacrylamide gel electrophoresis (SDS-PAGE). The components of the 
resolving gel and the stacking gel are summarized in Table 7.1. The samples 
were loaded after the completion of gels casting, and the gel electrophoresis 
was performed at a constant voltage of 200 V for 30 minutes. Finally the gel 
was stained by comassie brilliant blue staining solution. 
 
7.2.3 Hybridization of oligo 2 and oligo 1-invertase conjugates 
 To 40 µL of 1.0 mM oligo 2, 1060 µL of Buffer A and 200 µL of oligo 1-
invertase conjugates were added and mixed. The mixture was placed in a 38 
C water bath for 2.5 hours. Thereafter, the solution was purified by 100K 
filter with Buffer A. The resulting solution (ds-DNA-invertase) was made up 
to 200 µL with buffer A and stored at 4 C for further use. 
 
7.2.4 Immobilization of ds-DNA-invertase onto magnetic beads 
100 L of 10 mg/mL streptavidin coated MB were firstly washed twice with 
the 1×B&W buffer (1 M NaCl, 0.5 M EDTA, 5 mM Tris HCl, pH 7.4) 
recommended by the protocol from Invitrogen, then the magnetic beads were 
re-suspended in 200 L buffer B. To immobilize the as-prepared ds-DNA-
invertase onto the magnetic beads, 20 L of the as-prepared ds-DNA-invertase 
were mixed together with the 200 L magnetic bead suspension. The mixture 
was placed on a shaker for 20 minutes, allowing the ds-DNA-invertase to 
immobilize onto the magnetic beads through avidin-biotin interaction. After 
the immobilization, the magnetic bead-ds-DNA-invertase conjugates were 
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separated by magnet and washed with buffer B (0.1 M NaCl, 0.1 M sodium 
phosphate buffer, pH 7.3, 0.5% Tween-20). 
 
7.2.5 Optimization 
To optimize the digestion time of HpaII endonuclease, the magnetic bead-
dsDNA-invertase conjugates obtained after the immobilization were re-
suspended in 200 L 1×CutSmart buffer containing 200 U/mL HpaII, after 
placing in the 38 C water bath for 5, 15, 30, 60, 90, and 120 minutes, 
respectively, the magnetic beads were separated and washed with buffer B. 
The obtained magnetic beads were transferred into 10 L of 1.0 M sucrose in 
buffer B, and placed on the shaker for 50 minutes. Finally, the produced 
glucose was detected by the PGM. 
To optimize the methylation time of M.SssI MTase, the magnetic bead-
dsDNA-invertase conjugates obtained after the immobilization were re-
suspended in 200 L 1×NEBuffer 2 containing 40 U/mL M.SssI MTase and 
160 M SAM. After placing on the shaker for 0.5, 1, 2, 3, and 5 hours, 
respectively, the magnetic beads were separated and washed with buffer B. 
And the obtained magnetic beads were treated with 200 U/mL HpaII for 1 
hour, and then transferred to 10 L 1.0 M sucrose.    
 
7.2.6 Detection of M.SssI MTase activity using the PGM      
The M.SssI activity detection procedure was conducted similarly with the 
methylation time optimization procedure, except for that the methylation time 
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was fixed at the optimal and different concentrations of M.SssI were 
introduced. 
 
7.2.7 Selectivity study 
The selectivity of the proposed M.SssI activity biosensor was investigated 
by using HaeIII, AluI, and Dam MTases as the interference enzymes. The 
procedure was similar to the M.SssI activity detection procedure, except for 
that interferant MTases replaced M.SssI in the selectivity study. All the 
MTases were fixed at 40 U/mL. 
 
7.3 Results and discussion 
7.3.1 Principle and feasibility of the portable M.SssI MTase activity 
biosensor  
As illustrated in Figure 7.1, to adapt the PGM for M.SssI MTase activity 
sensing, invertase was conjugated with substrate DNA as the report probes. 
The DNA-invertase conjugates are immobilized onto streptavidin coated 
magnetic beads via the biotin-DNA capture probe. The duplex DNA segemnt 
is designed to contain the 5’-CCGG-3’ sequence, which is methylated by 
M.SssI MTase. After the methylation, the subsequent treatment with HpaII 
endonuclease is blocked by the methylation sites, while the unmethylated 
duplex DNA along with invertase is cleaved off from the magnetic beads. 
Finally, the glucose produced from the remaining invertase catalyzed 
hydrolysis of sucrose is detected by the PGM. Thus, the PGM readout is 




Figure 7.1. A schematic illustration of the principle for the detection of 
M.SssI MTase activity using the personal glucose meter. 
 
The oligo 1-invertase conjugates was characterized by 8% SDS-PAGE, the 
protein staining gel image was shown in Figure 7.2. The migration of oligo 1-
invertase conjugates in lane 3 is less than that in lane 1. This is due to the 
conjugation of the thiol-DNA with invertase, increasing its molecular size. 
Hence, the DNA-invertase conjugate band will move slower than the free 
invertase band in lane 1. Minimal difference was observed, in terms of band 
positions, between lanes 1 and 2. This was due to the fact that the oligo 1 not 
being conjugated with invertase in this mixture of invertase and oligo 1. These 




Figure 7.2. 8% SDS-PAGE characterization of oligo 1-invertase conjugate by 




The feasibility studies were carried out and the results are shown in Figure 
7.3. In control 1, there was no methylation or digestion been carried out, the 
PGM signal showed “Hi”, beyond the detection limit of the PGM. This 
suggested that the ds-DNA-invertase conjugates have been successfully 
captured onto the streptavidin coated magnetic beads and a large signal can be 
produced. For control 2, methylation was not carried out, but HpaII restriction 
digest was performed. The low signal indicated that 200 U/mL of Hpa II is 
enough to cleave off all invertase from unmethylated sites. On the other hand, 
Sample 1, upon methylation, showed a much larger reading than control 2, but 
less than that of control 1. This indicated that the methylation step does make 
effect, but not all ds-DNA have been methylated and thus have a lower signal 
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than that of control 1. This also showed that a larger or smaller M.SssI MTase 
concentration than 40 U/mL can be used in this study and the signal will still 
be within the detection limits. This study confirmed that the biosnesor 
proposed is feasible for the detection of M.SssI MTase activity. 
 
Figure 7.3. The PGM responses for control 1 (methylation: -, digestion: -), 




As the endonuclease digestion efficiency and the MTase methylation 
efficiency are closely associated with the final PGM readout, the digestion 
time and methylation time were optimized to achieve better results. Figure 7.4 
shows the time dependence of the PGM signal when the magnetic bead-ds-
DNA-invertase conjugates were treated with 200 U/mL HpaII. There was a 
sharp drop in the PGM signal between 5 and 30 minutes, before reaching a 
plateau after 60 minutes. This indicates that 60 minutes is the optimum 




Figure 7.4. The effect of digestion time on the PGM signal. 
 
  
Next, the HpaII digestion time was fixed at 1 hour, the methylation time 
was optimized. Figure 7.5 depicts the dependence of the PGM signal on the 
methylation time. The PGM signal increased with increasing methylation time, 
and reached a plateau after 3 hours. Hence, 3 hours was chosen as the optimal 
methylation time. Therefore, a period of 1 hour HpaII digestion and 3 hours of 
M.SssI MTase methylation time have been chosen as the optimal reaction 




Figure 7.5. The effect of methylation time on the PGM signal. 
 
7.3.3 Calibration study 
Under the optimal experimental conditions, the relationship between the 
activity of M.SssI MTase and PGM signal was investigated. From Figure 7.6, 
it was observed that the PGM signal increases with increasing concentration of 
M.SssI MTase linearly. This is because, a higher M.SssI MTase concentration 
leads to a higher methylation activity and that this allows more strands of the 
DNA duplexes to be methylated, effectively blocking more recognition sites 
of HpaII restriction enzyme. This leads to more invertase moieties remain on 
the magnetic beads to produce a greater signal. The regression equation within 
the linear range of 0.5 – 80 U/mL is y = 0.3863 x + 1.9961 (R2 = 0.9904) 
where y is the PGM signal (mM) and x is the concentration of M.SssI MTase 
(U/mL). A detection limit of 0.37 U/mL, using the 3 times standard deviation 




Figure 7.6. Calibration plot between the PGM signal and M.SssI MTase 
activity. 
 
7.3.4 Selectivity study of the proposed M.SssI MTase activity biosensor 
Other DNA MTases which act as interferants were added to test the 
selectivity of this iosensor. The MTases used were AluI, HaeIII, and Dam 
DNA MTases, at 40 U/mL each, the same concentration as M.SssI MTase. As 
seen in Figure 7.7, M.SssI MTase showed a much higher PGM signal than 
those of all other DNA MTases, while those DNA MTases showed similar 
readings which are close to the control sample (no DNA MTases added). This 
good selectivity is due to the unique recognition sequences of DNA MTases. 
Each of the interfering DNA MTases has a different recognition sequence 
from that of M.SssI MTase (5’-CG-3’). The recognition sequences of each of 
the interfering DNA MTases are 5’-GATC-3’ (Dam), 5’-AGCT-3’ (AluI), and 
5’-GGCC-3’ (HaeIII). Hence, since those DNA MTases have specific 
recognition sites which are not overlapping with M.SssI MTase, they do not 
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methylate at 5’-CCGG-3’ sequence. As there is no methylation at this 
sequence, HpaII can recognize and digest more methylated substrate DNA-
invertase conjugates and hence producing the low PGM signal. 
 
Figure 7.7. Selectivity of the proposed M.SssI MTase activity biosensor 




In conclusion, a portable and robust DNA MTase activity biosensor was 
successfully constructed by using a personal glucose meter as the signal 
readout. This biosensor showed good analytical performance of a wide linear 
range, a low detection limit, and excellent selectivity. Attributing to the 
pocket-size, low cost, ease of operation, and readily accessibility of the 
glucose meter, the proposed DNA MTase biosensor may act as flexible device 




Chapter 8. Conclusion and future outlook 
 
8.1 Conclusion 
In summary, this thesis mainly focused on the design and construction of 
sensing platforms for glucose and DNA MTase activity detection. In terms of 
these two different kinds of targets, this thesis could be concluded in the 
following two sections, respectively. 
 
8.1.1 Glucose biosensors 
In Chapter 2, by incorporating –SO3H groups in the polymer backbones of 
Os-RP, the constructed Os-RP/GOx/GCE biosensor was demonstrated to 
possess marked improvement of the anti-interference ability. Results showed 
that the presence of 0.1 mM ascorbic acid and 0.2 mM uric acid contributed 
less than 5% to the overall analytical signal. The remarkable anti-interference 
ability was largely due to the strong electrostatic repulsion between the high 
density of sulfonic acid groups presented in Os-RP and ascorbic acid/uric acid 
under physiological conditions, which greatly suppress the access of these 
anionic species to the biosensor.  
In Chapter 3, another approach of lowering the operating potential of the 
mediator was adopted to overcome the interference problem in amperometric 
glucose sensing. In this project, [Ru(NH3)6]
3+
, which has already been 
reported to have a relatively low operating potential (0 mV, vs. Ag/AgCl) 
when used as the mediator in glucose sensing, was further tethered to PVPAA. 
The successful tethering of [Ru(NH3)6]
3+
 to PVPAA via ligand exchange was 
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confirmed by FT-IR and UV-vis spectrometry. As expected, the redox 
potential of [Ru(NH3)6]
3+
 was shifted from -0.14 V to -0.28 V after the 
formation of the Ru-RP. Next, using the Ru-RP as the mediator, an 
amperometic glucose biosensor was successfully constructed through the co-
immobilization of the Ru-RP and glucose oxidase (GOx) on a glassy carbon 
electrode via a simple one-step chemical crosslinking process with 
glutaraldehyde. The glucose biosensor displayed excellent catalytic activity 
toward the oxidation of glucose with a current sensitivity of 24.3 A mM−1 
cm
−2
 and a linear correlation between the oxidation current and glucose 
concentration up to 10 mM. More importantly, owing to the low operating 
potential of −0.15 V (vs. Ag/AgCl), potential interferences from ascorbic acid, 
dopamine, uric acid, and acetaminophen were effectively alleviated. 
Overall, these two types of smartly designed mediators, the Os-RP and Ru-
RP, realize the interference-freely detection of glucose, which may give more 
options for mediators used for reliable glucose biosensing. 
In Chapter 4, lamellar ridge-Au with nanograin size and submicrometer 
structural arrangement using blue scales of Morph butterfly as templates was 
prepared by an electroless deposition method. Unarchitectured gold (flat-Au) 
was also synthesized as a control using the flat wing membranes as templates 
under the same conditions. The morphology and components of the gold 
materials were characterized by SEM, XRD, XPS, and TGA. Both the 
architectured and unarchitectured gold samples were coated on glassy carbon 
electrodes with Nafion for amperometric detection of glucose in an alkaline 
medium, with the aim of exclusively demonstrating the architecture effect on 
electrochemical sensing behavior. Prominent performance in the detection of 
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glucose was achieved with the lamellar ridge-Au modified electrode with a 
wide linear range from 2 μM to 23 mM. The sensitivity was 5.8 times higher 
than that of the flat-Au modified electrode. Also, the detection limit was 
lowered by 3.7 times to 0.87 μM compared to its unarchitectured counterpart. 
The architecture assisting effect was attributed to the combined effect of 
increased surface area and efficient mass transport, which was demonstrated 
by finite element simulation. This work presents an exemplary strategy for 
optimizing nanograin assembled configurations and may provide a useful 
strategy for future structural design of efficient electrochemical biosensors by 
drawing inspiration from butterfly-scale architectures. 
 
8.1.2 DNA MTase activity biosensors 
In Chapter 5, a previously reported electrocatalytic oxidation of AA by a 
threading intercalator [N,N'-bis(3-propylimidazole)-1,4,5,8-naphthalene 
diimide (PIND) functionalized with electrocatalytic redox Os(bpy)2Cl
+
 
moieties (PIND-Os)] was employed as the signal generator and amplifier for 
DNA MTase activity detection. PIND-Os specifically inserts itself between 
base pairs of ds-DNA and catalyzes the electrooxidation of AA at ~0.22 V 
owing to the improvement in the reversibility of the electron transfer from AA 
to the substrate electrode. This MTase biosensor was constructed by 
immobilizing the substrate ds-DNA of M.SssI onto a gold electrode and the 
defective sites of the ds-DNA layer were blocked by MCH. Treatments with 
MTase/endonuclease resulted in the methylation related retaining of ds-DNA 
onto the electrode surface. It was found that each step of modification 
successfully proceeded through the EIS and DPV characterizations. The 
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remaining amount of ds-DNA, which reflected the methylation level, 
determined the amount of PIND-Os and the final AA electrocatalytic current. 
As a result of the catalytic reaction, a high current sensitivity of 0.046 μA mL 
U −
1
 was achieved for M.SssI activity detection. In addition, it was 
demonstrated that this M.SssI activity biosensor exhibited absolute selectivity 
due to the specific sequence recognition. Finally, the inhibitor screening 
ability of this biosensor was demonstrated by using 5-Aza and 5-Aza-dC as 
the inhibitor models.      
In Chapter 6, depending on the similar DNA MTase coupled methylation 
sensitive endonuclease strategy described in Chapter 5, a simple and robust 
fluorometric Dam MTase activity biosensor was constructed. Firstly, MoS2 
nanosheets were successfully prepared through a mixed solvent assisted 
exfoliation method, and characterized by AFM and UV-vis spectrometry to 
confirm its morphology and the concentration of their suspension. Thereafter, 
the fluorescence quenching of FAM-labeled Dam MTase DNA substrate by 
the MoS2 nanosheets was studied in detail (e.g. quenching mechanism, 
experimental conditions). The MoS2 nanosheeets were confirmed to be an 
effective quencher for fluorometric Dam MTase activity detection. Finally, the 
analytical performance of this biosensor was evaluated. It was found that the 
linear range was from 0.2-20 U/mL, and the detection limit was estimated to 
be 0.14 U/mL. The selectivity and inhibitor screening ability were 
demonstrated as well. 
Lastly, in Chapter 7, a portable M.SssI MTase activity biosensor was 
developed by using a personal glucose meter as the signal readout. Similar 
MTase/endonuclease couple employed in the last two MTase activity 
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biosensors was adopted. Invertase, which acts as the signal producer, was 
conjugated with the substrate DNA through a sulfo-SMCC chemical 
crosslinker. Streptavidin coated magnetic beads were used for the substrate 
DNA immobilization and for the separation after the methylation/cleavage 
step. Finally, the produced glucose in the invertase catalyzed hydrolysis of 
sucrose was monitored by the PGM. This simple, robust, and portable MTase 
activity biosensor showed good analytical performance as well.    
                              
8.2 Future outlook 
In this dissertation, two types of mediated enzymatic glucose biosensors 
mainly aim at the improvement of anti-interference capability. Although the 
interference-free detection of glucose is remarkably realized, some other 
capabilities like the linear range, long-term storage stability, anti-biofouling 
capability of the sensing membrane are not up to the mark when compared 
with some other reported glucose biosensors. Further efforts are required to 
improve these aspects in order to apply them in real blood sample analysis. 
The third glucose biosensor based on the architectured gold is a nonenzymatic 
type of electrochemical glucose biosensor, its operation potential is relative 
high. Even though a wide linear range, high sensitivity, and a low LOD were 
achieved, the intrinsic drawbacks of the nonenzymatic methods, such as poor 
selectivity, may hinder the wide application of this glucose biosensor. Thus, 
further improvements are also needed. 
The DNA MTase activity biosensors proposed in this dissertation targeted at 
M.SssI and Dam MTase that are separated from bacteria. Although they are 
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well established and may provide effective approaches for drug (e.g. MTase 
inhibitors) discovery, they are all restricted to the proof-of-concept study and 
no real sample analysis is performed. In fact, if the substrate DNA in these 
studies could be replaced by the hemi-methylated DNAs, these proposed 
biosensors could in principle be adapted to detect human MTase (Dnmt1) 
activity. As the work conducted by Barton’s group,250, 251 it will be of great 
significance if experiments based on human DNA MTases can be carried out 
in the future. Apart from the target MTase, another kind of endonuclease is 
involved in these proposed biosensors. So far, this kind of multiple-enzyme 
strategy is also the most popular one adopted for MTase activity detection. 
However, as we all know, enzymes are usually fragile, sensitive to 
environment, and/or unsuitable for long-term storage. Thus, further efforts to 
minimize the number of enzymes employed for the MTase activity detection 
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